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Synopsis 
 
Microbiological research has uncovered the basis of fermentation, infectious disease, 
vaccination and antibiotics. Now, a technological revolution leveraging DNA, the code 
of life, has allowed us to unravel cellular and evolutionary processes in exquisite detail. 
Today our need for new innovation is still great. The modern world is a challenging 
environment: over-population, climate change and highly mobile populations create a 
high risk of pandemic disease especially from viruses and many bacteria are now 
resistant to our life saving antibiotic drugs due to overuse. In hospitals, the spread of 
pathogens can be rapid and life threatening. Whole-genome sequencing has the power 
to identify the source of infections and determine whether clusters of cases belong to an 
outbreak. Portable, real-time nanopore sequencing enables sequencing to be performed 
near the patient, even in resource-limited settings. Integrating with existing datasets 
allows digital surveillance able to detect outbreaks earlier while they can still be 
contained. Early demonstrations of the power of whole-genome sequencing for outbreak 
surveillance have made it an area of intense interest and further development in 
laboratory methods and infrastructure will make it an important tool that can be 
deployed in response to future outbreaks. 
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1. Introduction 
 
1.1 The discovery of microbes 
 
The first descriptions of microorganisms were made by Antony van Leeuwenhoek in 
1676[1]. Using his homemade microscopes, developed for inspecting the quality of 
cloth, he observed a menagerie of tiny ‘animalcules’ in samples of lake water and 
plaques from his own teeth. He notified the Royal Society, who were initially sceptical, 
but commissioned Robert Hooke to build a powerful microscope. Hooke successfully 
reproduced a bizarre experiment Leeuwenhoek had conducted to see if black pepper 
was covered in points which were responsible for its sharp taste. He mixed ground 
pepper with water, and days later he discovered it teeming with microbes. The Royal 
Society were convinced and made him a Fellow and the field of microbiology was born. 
 
1.2 The ‘Golden age’ of bacteriology 
 
1.2.1 Pasteurisation 
 
Two hundred years later, Louis Pasteur and Robert Koch ushered in the ‘Golden Age of 
Microbiology’. They unravelled many fundamental microbial processes and their 
relationship to disease during this period. Pasteur wished to understand the 
microbiology of food spoilage organisms. He discovered the process of alcoholic 
fermentation by yeast and that contamination by another microorganism could turn wine 
into vinegar. He devised his method of heat sterilisation which was later routinely 
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applied to beer and milk[2]. In a famous experiment, he used swan-necked flasks to 
show if bacteria could not fall into sterile broth then it would not become contaminated. 
This was strong evidence against the popular theory of spontaneous generation[3] 
whereby living organisms could arise from inanimate matter.  
 
1.2.3 Discovery of the anthrax bacillus 
 
Robert Koch was a German physician and has been described as the ‘father of medical 
microbiology’. Koch built on Pasteur’s work on germ theory in order to confidently 
attribute diseases to infection by particular microbial species. While investigating 
anthrax deaths in humans and livestock, Koch demonstrated that the disease could be 
transferred to healthy animals by inoculating them with blood from diseased animals. 
Further, the presence of rod-shaped bacteria in the blood was required for disease 
transmission. He went on to demonstrate the role of spores in anthrax lifecycle and how 
their presence in contaminated soil could make it infectious for years. He later 
discovered the microbes responsible for tuberculosis and cholera. 
 
1.2.4 Koch’s plate technique 
 
Koch demonstrated the utility of culture in medical microbiology through the use of his 
plate technique[4]. During his studies on anthrax he noticed that the rods were often 
elongated and notched and suspected this related to how the cells reproduced. He 
realised that culture needed to take place on solid media to ensure that cultures were 
‘pure’ i.e. derived from one starting cell. This led him to develop agar media which 
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bacteria grow well on and stays solid at temperatures needed for incubation. He grew 
his cultures in a shallow dish with an overhanging lid to prevent contamination invented 
by his assistant Petri.  
 
1.2.5 Koch’s postulates 
 
Based on the techniques he had available to him, Koch devised a set of rigorous 
guidelines for determining the causality of disease. They required that the pathogen be 
present in all diseased individuals, be isolated in pure culture and that the pure culture 
be able to cause disease in a healthy animal model. These would remain unfulfilled if 
the organism was unculturable or for viral infections until the invention of the electron 
microscope. 
 
 
Figure 1. Koch’s postulates for causality of disease reproduced from 
http://ocp.hul.harvard.edu/contagion/koch.html. 
 
 
1. Infected tissue must show the presence of a particular microorganism not 
found in healthy animals. 
2. The microorganism must be isolated and grown in a pure culture. 
3. When injected into a healthy animal, the microorganism must cause the 
disease associated with it. 
4. This “second generation” microorganism should then be isolated and shown 
to be identical with the microorganism found in 1. 
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1.3 Antimicrobial compounds 
 
1.3.1 History of early antibiotics 
 
The first effective antimicrobial drug was Salvarsan, an arsenic compound synthesised 
in Paul Ehrlich’s lab. Ehrlich screened many compounds in the hope of finding a ‘magic 
bullet’ that was not fatally toxic to the patient. The search paid off in 1909 when his 
assistant Sahachiro Hata showed he could cure a Guinea pig of a spirillum infection 
using a compound known as ‘Compound 606’. Subsequent human trials showed it was 
an effective treatment for syphilis and proved to have few side effects. Sulphonamides 
such as Prontosil introduced in 1932, were the first effective antibiotics that could be 
taken orally to treat systemic infections. The compound inhibits bacterial growth by 
blocking folic acid synthesis which is required to make nucleic acids. This led to dozens 
of related compounds being produced and as the only effective antibiotic available 
before penicillin it was used to treat many conditions. A related compound, 
Sulfamethoxazole is still in use today usually in the form of co-trimoxazole for treating 
urinary tract infections. 
 
Penicillin, one of the most celebrated antibiotics, is an antimicrobial compound 
produced by the fungus Penicillium notatum. After returning from holiday 
microbiologist Alexander Fleming noticed a mould had contaminated his plates and that 
there were no staphylococci colonies growing close to it[5]. He realised that the fungus 
was producing a bactericidal substance and showed it was able to kill a number of other 
important pathogens. Research into the mass production of penicillin eventually led to 
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the production of 2.3 million doses of penicillin by the end of the World War II. 
Penicillin quickly became indispensable and doctors prescribed it for infections of 
gonorrhoea, streptococci and staphylococci. Fleming had warned about the dangers of 
misuse of penicillin as he has observed bacteria acquire resistance to it in the 
laboratory[6], however the use of the miracle drugs grew exponentially. The first 
penicillin resistant Staphylococcus aureus were detected as early as 1947[7] and for all 
new classes of antibiotics such as aminoglycosides, chloramphenicols and tetracyclines, 
resistant strains were detected within a few years of each being used[8]. 
 
1.4 Phenotypic identification 
 
1.4.1 Microbial identification 
 
Microbes are classified using phenotypic properties including cellular morphology, 
cellular aggregation and metabolic capability. Morphologies include cocci, bacilli, 
filamentous and spirochete forms with cocci being subcategorised by arrangement such 
as diplococci and chains. Staining can make bacteria more visible through a 
microscope: the most famous being the Gram stain developed by Hans Christian Gram 
in 1884[9]. The technique involved a primary stain of crystal violet and counterstain of 
safranin which gave a binary classification of most bacteria, depending on the 
peptidoglycan content of the cell wall. Many viruses are too small to be seen by a light 
microscope they could not be seen until the invention of the transmission electron 
microscope in 1935, however the presence of aggregates e.g. Negri bodies in Rabies 
infection were used to detect viruses before this.  
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1.4.2 Biochemical tests 
 
Bacteria can be identified via their metabolic functions using a panel of biochemical 
tests. For example, the catalase test is used to distinguish Staphylococcus species from 
other aerobic cocci. Catalase producers metabolise hydrogen peroxide into water and 
oxygen gas which is observed as bubbles. The coagulase test can further identify 
Staphylococcus aureus from other Staphylococcus species. The presence of coagulase 
mean fibrinogen is converted to insoluble fibrin which turns the liquid solid. These tests 
are very common in clinical microbiology labs as they are quick and relatively simple. 
They are commonly automated on machines performing many tests simultaneously on 
cards such as in the bioMérieux VITEK 2 which can perform automated identification 
and susceptibility testing. 
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Figure 2. Reproduced from http://step1.medbullets.com/microbiology/104192/gram-
positive-bacteria showing how you would identify Gram-positive bacteria such as 
Staphylococcus aureus using phenotypic methods.  
 
1.4.3 Antibiograms 
 
Bacterial antibiotic susceptibility testing is typically performed using the disc diffusion 
method. A disc containing a known concentration of antibiotic is added to a Petri dish 
of growing bacteria. The bacteria will grow until they become inhibited by the antibiotic 
diffusing from the disc. The size of the inhibition zone indicates effectiveness of the 
antibiotic at inhibiting bacterial growth. The assay allows multiple antibiotics or 
concentrations to be tested on the same plate. Antibiotic sensitivity testing is primarily 
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used for prescribing an effective antibiotic to treat an infection but as patterns in 
antibiotic sensitivity vary greatly even within a species, patterns of sensitivity or 
resistance can be used as evidence in epidemiological investigations. 
 
1.4.4 Phage typing 
 
Phage typing uses panels of bacteriophages to discriminate between bacterial strains. A 
grid is drawn on a plate and different bacteriophage are added to each region. 
Bacteriophage are highly diverse yet have a narrow host range as they can only infect 
bacteria with receptors to which they can bind. The pattern of lysis by different 
bacteriophages provides the phage typing profile. If two isolates produce the same 
phage pattern that is used as evidence that they are closely-related strains.   
 
1.5 Genotypic identification 
 
Combinations of phenotypic tests have defined the classical microbial taxonomy used in 
clinical microbiology today. However, phenotypic tests suffer from numerous 
limitations; they rely on culture so are difficult for slow growing or fastidious organisms 
e.g. Mycobacterium tuberculosis, multiple tests are required to identify each organism 
and the interpretation of test results can be very subjective[10]. Therefore genotypic 
tests relying on molecular methods such as the polymerase chain reaction and 
deoxyribonucleic acid sequencing are gradually replacing phenotypic methods. 
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1.5.1 Deoxyribonucleic acid (DNA) 
 
 
DNA and ribonucleic acid (RNA) are polymers made up of nucleobases that store 
genetic information and are essential to all known life. In 1928, Frederick Griffiths 
performed an experiment demonstrating that an unidentified transforming principle 
could induce a change from non-capsular to capsular in Streptococcus pneumoniae[11]. 
The first demonstration that the transforming principle was DNA came from Avery-
MacLeod-McCarty experiment in 1944[12]. At the time it was widely assumed that the 
heritable material would be protein but Avery and colleagues managed to carefully 
separate DNA from the rest of the cellular components and show that it alone possessed 
transformative capability. Later, further confirmation that DNA is the transforming 
substance came in 1952 from Hersey and Chase[13] in an elegant experiment where 
they labelled T2 phage with radioactive isotopes of either phosphorus or sulphur. The 
progeny of these phages contained radioactive phorphorus but not radioactive sulphur 
proving that the genetic material was DNA not protein. The structure of DNA and 
model for semi-conservative replication was proposed by Crick and Watson in 1953[14] 
by formulating a model that fitted known chemical properties of nucleic acid and 
interpretation of a X-ray diffraction photo taken by Rosalind Franklin. Crick later 
published the ‘central dogma of molecular biology’[15] which stated that genetic 
information flowed from DNA to RNA to protein in general transfers as well as other 
information flows such as RNA to DNA in special circumstances. Critically, however, 
once genetic information is encoded in proteins, it cannot transfer back again. 
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1.5.2 The polymerase chain reaction (PCR) 
 
PCR is a system for the amplification of DNA targets using short oligonucleotide 
primers. It was a developed by Kary Mullis while working at Cetus Corporation who 
were developing a diagnostic assay for sickle cell anaemia[16]. Mullis realised that he 
could modify existing polymerase extension methods by adding a reverse primer on the 
opposite strand to achieve exponential amplification of a target region. The technique 
has revolutionised the detection of genetic mutations, the diagnosis of infectious 
disease, forensics and research. The components of the reaction are DNA template, 
forward and reverse primers, thermostable polymerase and deoxynucleotide 
triphosphates (dNTPs). Products of PCR are usually visualised using agarose gel 
electrophoresis, a technique used to separate DNA molecules by size; visualising a band 
on a gel of the expected size is indicative of a positive PCR. 
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Figure 3. Reproduced from http://www.discoverbiotech.com/wiki/-
/wiki/Main/Polymerase+Chain+Reaction showing the first 3 cycles of a PCR reaction. 
Cycling the temperature between 95°C for denaturation, 50-65°C for annealing and 
72°C generates two copies for each one in the previous cycle. 
 
1.5.2.1 Real-time PCR 
 
Real-time PCR combines a PCR with a fluorescent reporter to monitor the process of 
amplification. Such an approach removes the need to analyse products on a gel and 
provides more accurate quantification. There are two common methods of detection of 
PCR products, the first method uses an intercalating dye such as ethidium bromide 
which binds non-specifically to double stranded DNA meaning the fluorescence is 
proportional to the mass of DNA in the reaction. The second method uses a probe with a 
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fluorescent reporter at the 5' end and a quencher at the 3' end. This binds within the 
target and is cleaved by the exonuclease activity of the polymerase during extension. 
Once it is no longer in close proximity to the quencher, the dye fluoresces. The 
advantage of this system is that non-specific products such as primer dimer do not 
contribute to the fluorescence. Multiple dyes with different emission wavelengths can 
be multiplexed in the same reaction as long as the wavelength is supported by the qPCR 
instrument.  
 
1.5.2.2 The reverse transcription polymerase chain reaction (RT-PCR) 
 
RT-PCR a variant of PCR which enables amplification from an RNA template by 
incorporating a reverse transcription step at the start to generate cDNA. Standard PCR 
is then used to amplify a target from the cDNA. Reverse transcription in the 3' to 5' 
direction can be primed either using a specific primer such as oligo(dT) for poly(A) 
tailed mRNA or a random hexamer primer. If using a specific primer, reverse 
transcription and PCR can be performed in a single reaction known as one-step RT-
PCR, or RT-qPCR if quantitative. This method is common in diagnostic assays for viral 
infections as it involves fewer pipetting steps which reduces the chance of 
contamination. Using the fluorescence data collected during the run software will 
determine the cycle threshold (Ct) value, which is the cycle that the fluorescence 
increased above baseline. This value is inversely related to the copy number of the 
target in the starting sample. 
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Figure 4. Reproduced from https://bitesizebio.com/24581/what-is-a-ct-value/ showing a 
simulated amplification qPCR curve, Ct value is the cycle where the fluorescence curve 
intersects the threshold based on the background fluorescence. Amplification curves are 
sigmoidal as they are exponential in early cycles then plateau as the reagents are 
depleted. 
 
1.5.2.3 Multiplex PCR 
 
Multiplex PCR is the process of amplifying multiple targets in a single reaction by the 
inclusion of primers for more than one target. This could be in order to multiplex targets 
in the same qPCR assay, each with its own detection channel or for generating a pool of 
amplicons for sequencing with next-generation sequencing. Mixed pools of amplicons 
must be sequenced because only products of different lengths can be differentiated on a 
gel. This is also true of single genes amplified from mixed populations such as with 
barcode sequencing like the bacterial small ribosomal subunit 16S or mitochondrial 
CO1. 
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1.5.3 Pulsed-Field Gel Electrophoresis 
 
Pulsed-Field Gel Electrophoresis (PFGE) is a typing method in which the restriction 
digest patterns of different bacterial strains are compared. Genomic DNA is digested 
using a restriction endonuclease and the products are run by gel electrophoresis. It is not 
easy to separate molecules above 40 kb with a constant electrical field. In order to 
resolve fragments larger than this a pulsed-field system is required. Fragments up to 
several megabases in size can be resolved by pulsed-field by switching the direction of 
the electrical field which means molecules can zigzag through the gel. This works 
because it takes longer for large molecules to reorient in a fluctuating field which means 
they travel slower for a given set of switching conditions[17]. 
 
1.6 DNA sequencing 
 
DNA sequencing by the incorporation of chain-terminating di-deoxynucleotide 
triphosphates (ddNTP’s) was invented by Fred Sanger in 1977[18].  He found that by 
including a certain ratio of each ddNTP in four separate reactions, then performing a 
template extension by DNA polymerase he could read the sequence by gel 
electrophoresis of each reaction. This technology was used to sequence one the first 
complete genomes, of bacteriophage λ, earning Sanger his second Nobel prize.  
 
1.6.1 Multilocus sequencing typing (MLST) 
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The development of the polymerase-chain reaction (PCR) and Sanger sequencing led to 
the adoption of sequence-based typing methods. One of the most popular techniques is 
MLST in which sequence variation is determined in multiple (usually seven or eight) 
‘house-keeping’ genes. 450-500 bp fragments are amplified by PCR and sequenced[19]. 
The sequences at these loci are compared against those already in one of two databases 
(mlst.net/ and pubmlst.org/) to see if the allele has already been assigned a number. If 
the allele is novel a new number will be assigned centrally after verification. The set of 
alleles numbers is known as the allelic profile or the sequence type which are also 
curated in the database. MLST involves sequencing PCR products which makes it more 
reliable than PFGE which relies on laborious agarose plug extractions taking several 
days. It has represented a ‘gold standard’ in sequence typing for many years and a well-
designed scheme can provide good clustering however for genetically monomorphic 
species such as M. tuberculosis it can lack discriminatory power[20]. Today sequence 
types are still widely used however due to the continued decline in the cost of next-
generation sequencing (see 1.6.3) alleles are usually extracted from data generated using 
shotgun sequencing (1.6.2) often referred to as in silico sequence typing[21].  
 
1.6.2 Genome sequencing projects 
 
With the introduction of automated Sanger sequencing instruments in 1987, the 
sequencing of larger genomes became conceivable. Consortia were set up to sequence 
bacterial model species such as Escherichia coli and Bacillus subtilis. The Human 
Genome Project (HGP) was set up in 1990 with the even bigger ambition of sequencing 
the human genome. They planned to do this by the top-down method, firstly using 
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traditional linkage maps, followed by cloning of ordered large fragments of the genome 
into bacterial artificial chromosomes (BACs). These BACs were then fragmented and 
then assembled individually, before being combined into a larger whole-genome 
assembly. In 1995 Craig Venter stunned the world with the announcement that his team 
had sequenced the first bacterial genome, Haemophilus influenzae in just twelve 
months[22] using a pure whole-genome shotgun technique that bypassed the need to 
produce physical maps or BACs. A few months later they published the genome of 
Mycoplasma genitalium[23] the smallest known genome of any free-living organism. 
More complex genomes followed with Saccharomyces cerevisiae (12 Mb) in 1996 and 
Caenorhabditis elegans (100 Mb) in 1998 from other groups using the direct shotgun 
method. At the time it was not thought that the whole-genome shotgun method alone 
would be sufficient for large complex genomes such as human. However, by combining 
it with mate-pair and state of the art assembly software the private Celera corporation 
assembled Drosophila melanogaster (175 Mb) in 2000 and human (3.12 Gb) in 2001. 
Both the HGP and Celera simultaneously published manuscripts outlining drafts of the 
human genome assembly in Nature and Science respectively[24, 25]. The scale and 
complexity of these genome sequencing projects led to the rapid growth of very large 
specialist industrial-scale genome sequencing centres such as the Sanger Institute. 
 
1.6.3 The second revolution: next-generation sequencing 
 
The introduction of next-generation sequencing (NGS) using massively parallel 
sequencing dramatically reduced the cost of sequencing whole genomes. The launch of 
the 454 GS20 in 2005[26] was swiftly followed by the Solexa Genome Anayzer in 
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2006[27], both using a sequencing-by-synthesis (SBS) approach i.e. detecting single 
base incorporations by DNA polymerase into a growing population of clonal DNA 
clusters. The chemistry system used by 454 uses emulsion PCR to amplify library 
molecules on beads inside droplet reaction chambers. The sequence is determined by a 
microfluidic version of the existing pyrosequencing method in which a cocktail of three 
enzymes generate a detectable light signal: DNA polymerase which incorporates a 
dNTP releasing pyrophosphate, ATP sulfurylase which converts pyrophosphate to ATP 
and firefly luciferase which consumes ATP to produce light. In this system the intensity 
of light is approximately proportional to the number of bases incorporated at a given 
step. The Solexa chemistry by contrast uses a ‘reversible terminator’ chemistry with 
each base having a different fluorescent label. Bases are incorporated one at a time, but 
can be unblocked chemically to permit the next cycle of chemistry to proceed. A light 
source and a camera is used to read the most recently incorporated nucleotide’s 
fluorescent tag. Solexa was bought by Illumina in 2007 who have developed the SBS 
chemistry to increase read lengths to up to 300 bp and run throughput to up to 6 
terabases (6x1012 bases). The scalability proved decisive and in 2016 the 454 platform 
was withdrawn from sale due to uncompetitive running costs. 
  
1.6.3.1 Bench top instruments 
 
The Illumina MiSeq, released in the autumn of 2011, was one of a new breed of 
‘benchtop’ sequencers and has become heavily used for viral and bacterial whole-
genome sequencing[28]. Users are able to generate sufficient data to sequence up to 96 
bacterial genomes in 2-3 days for around $100 per sample. This meant universities and 
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public health laboratories, by running their own instrument instead of utilising academic 
genome facilities, could dramatically reduce the time taken to generate results. This 
facilitated the adoption of sequencing in cost restricted environments such as the UK’s 
National Health Service for performing bacterial typing, antibiotic susceptibility 
prediction and surveillance sequencing in a single assay[29]. 
 
1.6.4 The Third Revolution: Single-Molecule Sequencing 
 
1.6.4.1 PacBio SMRT sequencing 
 
The Sequel and RSII instruments sold by Pacific Biosystems (PacBio) use Single 
Molecule Real-Time sequencing (SMRT) sequencing to detect incorporation of 
fluorescently labelled bases by a polymerase in real-time. Sequencing reactions take 
place in zero mode waveguides (ZMWs) each too narrow for light to propagate into. 
The ZMWs each house an immobilised template-polymerase complex in the illuminated 
region at the bottom. Phospholinked nucleotides are present in the reaction chamber but 
only those being incorporated by the polymerase are in the excitation zone long enough 
to be detected, observed as flashes of light. As the fluorophore on the phosphate chain is 
cleaved off by the polymerase during incorporation and the fluorophore diffuses away. 
A movie is recorded then later analysed to determine the sequence of each temple. 
Although a sequencing-by-synthesis approach, modifications such as methylation can 
be inferred from their effect on the enzyme kinetics, relying on the observation that 
modified bases typically are slower to incorporate than unmodified bases[30]. 
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1.6.4.2 History of Nanopore Sequencing 
 
The concept for using nanopores to sequence DNA molecules directly was first devised 
by David Deamer in 1989[31], yet it has taken 25 years to overcome the many technical 
hurdles to develop the first commercial system. The first experimental evidence that the 
system could be used to sequence nucleic acids was produced in 1996 when 
Kasianowicz et al., who had been working closely with Deamer, detected translocations 
of RNA homopolymers through an ⍺-hemolysin pore[32]. As the technical details were 
fleshed out it became apparent that the translocation speed through he sensing region 
was on the order of 1-10 µs per nucleotide, even at low bias voltages. A way of 
ratcheting the DNA through the pore at slower speed was needed. After some mixed 
results using different classes of DNA polymerase, Mark Akeson discovered that phi29 
polymerase could be coupled to protein nanopores to ratchet DNA through the pore at 
2.5-40 nucleotides per second at single nucleotide resolution[33]. Crucially the enzyme 
could also be nanopore activated i.e. did not polymerise in the cis compartment when a 
negative bias voltage was applied. 
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Figure 5. Reproduced from[34]. (a) ssDNA translocating through the nanopore with 
phi29 DNA polymerase acting as a ratchet. Panels (b-d) show different types of pores 
that have been used to detect DNA. 
 
1.6.4.3 Principles of nanopore sequencing 
 
The key feature of a nanopore sequencing system is the nanoscale pore which is 
inserted into a membrane, traditionally a lipid bilayer. Either side of the membrane, the 
cis and trans compartments, are filled with ionic solutions. When a bias voltage is 
applied across the membrane, ions flowing through the pore produce an electrical 
current which can be detected using a sensitive ammeter. Negatively charged DNA 
molecules, when added to the cis compartment, are driven electrophoretically through 
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the pore. The disruption to the ionic current by the mass and electrical field of the bases 
in the pore cause a shift in the measured current. High-frequency sampling of the 
current as a DNA molecule is ratcheted through the pore generates an electrical current 
trace measured in pico-amps. The DNA sequence can be deduced by comparing the 
current trace to ones trained on known sequences. The ratchet enzyme slows down the 
translocation orders of magnitude allowing each base to remain in the pore long enough 
to detect it. 
 
1.6.4.4 Commercialisation of nanopore sequencing 
 
In June 2014, the MinION developed by Oxford Nanopore Technologies (ONT) 
became the first nanopore sequencing device to market. MinION was brought to market 
with a ‘Gillette’ cost model; low instrument price and profits generated on sales of 
disposable flowcells.  It represented a significant departure from all instruments before 
it being only the size of a USB dongle and drawing power from a laptop computer. The 
flowcell itself contains up to 2048 individual nanopores with a 4:1 multiplexer allowing 
data collection from 512 simultaneously using the MinKNOW control software, also 
developed by the company. The system was launched using an undisclosed protein 
pore. In March 2016, ONT announced that future products would utilise mutants of 
CsgG pore a lipoprotein from E. coli now known as ‘R9’ 
(https://nanoporetech.com/events/no-thanks-ive-already-got-one). The system employed 
a DNA helicase to act as the ratcheting ‘motor’ protein. The helicase is bound to the 
sequencing adapter but held in situ on a stretch of the adapter until activated by the 
electrophoretic force as it enters the pore. Another important innovation was the 
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inclusion of a cholesterol group which tethers the library onto the membrane. This 
produced a thousand times increase in sensitivity with respect to bulk phase sampling. 
The current traces (known as ‘raw signal’) are written into HDF5 format ‘FAST5’ files 
by the data collection software MinKNOW[35]. Basecalling is performed directly from 
raw using software called Albacore. Albacore is a neural network type basecaller using 
a model trained on E. coli, S. cerevisiae and human data. Homopolymers translocating 
do not result in current shift, but a type of neural network known as a transducer 
network is used which is capable of estimating the length of a homopolymer from the 
dwell time improving the accuracy of these basecalls 
(https://github.com/nanoporetech/scrappie). 
 
1.6.5 Sequencing library preparation methods 
 
Sequencing libraries for next-generation sequencing consist of a pool of fragments 
which could contain anything from one to trillions of unique molecules. It is in this 
regard where next-generation technologies fundamentally differ from Sanger 
sequencing and where the term massively-parallel sequencing originates from. Instead 
of generating copies of the template using cloning or PCR, amplification takes place on 
beads or attached to a surface forming a ‘colony’. This enables sequencing reactions to 
take place as a two-dimensional array of features facilitating detection. Generating 
libraries usually consists of taking some fragments of DNA or RNA and adding 
adapters onto the ends making them compatible with the sequencing chemistry. 
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1.6.5.1 PCR and PCR-free libraries 
 
Most types of NGS library preparation involve ligation of adapters for PCR 
amplification or sequencing. PCR amplified libraries suffer from GC bias, where GC 
rich or poor fragments are underrepresented in the library as a result of inefficient 
amplification. PCR-free libraries can be made with higher input however this does not 
fully alleviate the issue as 454 and Illumina sequencing require amplification for colony 
generation. By contrast, single molecule sequencing technologies do not require 
amplification and therefore should be immune to GC bias. Paradoxically, despite 
sensing single molecules they require extremely high amounts of input DNA. A typical 
Illumina or Oxford Nanopore PCR-free library requires 1 µg input material. The use of 
gel-based size-selection increases DNA input further due to sample losses. For PCR 
libraries Illumina Nextera XT libraries can be generated from as little as 1 ng using 12 
cycles of PCR. Generating PCR-free libraries is not practical for all sample types e.g. 
low biomass samples so library preparation methods for a variety of inputs are required. 
 
1.6.5.2 Mechanical fragmentation 
 
Genomic DNA (gDNA) is fragmented when a specific fragment size distribution is 
desired for a sequencing library. That may be a platform-specific decision such as 
matching the insert to the read-length in Illumina sequencing (typically 500-1000 bp) 
but can also occur when handling especially high-molecular-weight DNA and is usually 
unwanted. For Illumina sequencing in which a desirable range might be 100-1500 bp, 
fragmentation is often performed using Covaris focused-ultrasonication. For fragments 
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longer than 5000 bp hydrodynamic shearing using a Covaris g-TUBE or needle 
shearing gives more consistent results. In this method DNA molecules experience 
shearing forces as they pass through a narrow opening resulting in fragmentation.  
 
1.6.5.3 Ligation libraries 
 
In order to ligation adapters to random fragments they must first be end-repaired and 
dA-tailed. This is performed using a combination two enzymes, T4 DNA polymerase 
and Klenow fragment which remove 3' overhangs and fill in 5' overhangs. dA-tailing is 
used to avoid the formation of adapter concatemers during ligation. This adds to the 
time required to generate a ligation library. For systems that require colony 
amplification different adapters are required on each end of the library construct e.g. 
Illumina paired-end sequencing. Using two adapters (A and B) the possible ligation 
products also include A-insert-A and B-insert-B which will not amplify which results in 
low efficiency. The solution to this was the ‘Y’-adapter introduced by Solexa which 
uses a complementary region with two non-complementary regions needed for cluster 
amplification. During the first PCR cycle a single short primer generates two 
asymmetric products which are then amplified by a tailed long primer and the short 
primer. Oxford Nanopore libraries cannot be generated by PCR as the adapters contain 
modifications and the motor protein. If PCR amplification is used then adapters will be 
added by a separate adapter ligation step after. 
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Figure 6. Reproduced from https://community.nanoporetech.com. This figure illustrates 
three common methods for library preparation for Oxford Nanopore sequencing by end-
preparation and adapter ligation (left) or by tagmentation and adapter ligation (right). 
 
1.6.4.4 Transposase libraries 
 
An alternative to mechanical fragmentation is enzymatic fragmentation. This could be 
done using endonucleases either specific or non-specific or more desirably using a 
transposase enzyme. Transposases are the enzymes that facilitate the movement of 
transposons around the genome. They are now widely used in next-generation 
sequencing library preparation because they can perform a dual function of fragmenting 
and adapting genomic DNA. Transposases are complexed with double stranded adapters 
by incubating in the absence of cofactor Mg2+ forming a transpososome, these adapters 
will eventually be attached to the ends of the DNA at the cut sites in a process known as 
tagmentation. The length of fragments generated by tagmentation will be dependent on 
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the starting fragment size, the mass of DNA and the molarity of transposomes. By 
controlling the molarity of transpososomes you can control the molarity of tagmented 
fragments and increasing the mass of input DNA will increase the fragment size. These 
enzymes are used in both the popular Nextera XT kit (Illumina) utilising a Tn5 mutant 
and the Rapid sequencing kit (Oxford Nanopore Technologies) utilising MuA 
transposase. By combining fragmentation and adapter attachment these methods are 
among the fastest library preparation methods in use and are also compatible with PCR 
and barcoding. They are not suitable for amplicon sequencing as they cut in the middle 
of fragments resulting in lower coverage of the ends of the amplicon with respect to the 
middle.  
 
1.6.5.5 Sample barcoding 
 
Molecular barcoding is used to multiplex many samples into the same flowcell or lane, 
this way the barcode can be sequenced in order to separate reads later in a process 
known as demultiplexing. Barcodes are short sequences introduced during library 
preparation which allow multiple samples to be pooled in a library. They are usually 6 
or 8 bases long in Illumina sequencing or 24 bases for Oxford Nanopore due to the 
lower basecalling accuracy. They can be introduced either during PCR, by a transposase 
or by ligating double stranded oligonucleotides to fragments in PCR-free libraries. Dual 
indexing strategies using different barcodes on each end of the molecule allow for large 
number of barcode combinations i.e. 96 combinations are achieved using 8 × 12 
barcode sequences. Multiplexed sequencing can be used to reduce the cost per sample 
when the full output of a flowcell or lanes excessive for a single sample. 
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1.7 Comparative genomics  
 
The success of Sanger shotgun sequencing and then next-generation sequencing 
launched the field of comparative microbial genomics. Analysis of the genome of 
Mycobacterium leprae, a species adapted to an isolated niche, found it had undergone 
extensive genome reduction compared with Mycobacterium tuberculsosis. This was 
characterised by accumulation of pseudogenes or the complete deletion of genes no 
longer needed for survival[36]. By 1999 there were two genomes available for the same 
species[37], Helicobacter pylori. The genomes were found to be quite similar in 
structure and gene order. A small percentage of the genes were unique to one strain or 
the other, with half of these genes clustered in a hypervariable region of lower %GC 
suggesting they could have been acquired by horizontal gene transfer.  
 
1.7.1 Horizontal gene transfer 
 
Horizontal gene transfer is the transfer of genetic material from one organism to 
another. In prokaryotes it can occur in three ways; transformation, transduction or 
conjugation[38]. Transformation is a natural process by which competent cells bind, 
take up and recombine exogenous DNA into its chromosome. Integrated DNA is 
usually derived from a closely related organism so occurs by homologous 
recombination. Transduction is the process by which DNA is transferred from one cell 
to another via a viral vector. This occurs when small pieces of bacterial DNA, either 
adjacent to the phage insertion site or from somewhere else in the bacterial genome are 
packaged into the phage genome. In what is known as ‘generalised transduction’ a 
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stretch of bacterial DNA is packaged into the viral envelope by accident. If the phage 
infects another bacterial cell the DNA can integrate into the hosts genome by 
homologous recombination. In the alternative method ‘specialised transduction’ 
bacterial genes with close proximity to the prophage are included in the excised DNA. 
This is then packaged into a new virus, which after infecting another cell may be 
integrated into its genome. Conjugation or ‘bacterial sex’ is the exchange of a genetic 
material, either a plasmid or transposon via direct cell-to- cell contact. 
 
1.7.2 Recombination 
 
Recombination in prokaryotes can be homologous or non-homologous. Homologous 
recombination occurs between closely related organisms due to high sequence 
similarity, with the frequency of homologous recombination events falls exponentially 
with decreasing sequence identity. Non-homologous recombination can occur between 
organisms with no sequence homology as it utilises a double strand break repair system. 
As non-homologous recombination events may reduce the likelihood of homologous 
recombination they may be serve as speciation ‘seeds’ which lead to diversification 
between strains[39]. 
 
1.7.3 Plasmids 
 
Plasmids are extrachromosomal replicons (replicative unit), that are inherited by 
daughter cells during cell division and are also capable of horizontal transfer into other 
species or genera. They typically vary in size from a few kilobases to hundreds of 
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kilobases and are found throughout the bacterial and archaeal kingdoms. Plasmids may 
carry genes (‘cargo’) that may confer a selective advantage such as resistance to a 
particular antibiotic. Some may not have any useful function yet are maintained by 
‘addiction systems’ such as toxin-antitoxin system in which a plasmid encodes both a 
toxin and an antitoxin, meaning the bacterium will be killed by the toxin if the plasmid 
if lost. 
 
1.7.4 Integrative conjugative elements 
 
Integrative conjugative elements (ICE) are similar to conjugative plasmids however 
they lack an origin of replication and the genes required to make the conjugation 
machinery, they have to therefore integrate into a chromosome or plasmid in order to 
persist. The advantage of this is they can integrate into a broader range of hosts, as they 
do not reply on conjugation machinery being compatible with the host 
 
1.8 Epidemiology 
 
1.8.1 History 
 
Epidemiology is the study of patterns of disease within a population. John Snow, known 
as the father of modern epidemiology, famously investigated a cholera outbreak in the 
Soho district of London in 1854[40]. By talking to local residents and creating a map of 
cholera cases he was able to identify a water pump as the source of the outbreak. 
Removing the water pump’s handle ended the outbreak. Both Pasteur and Koch also 
 39 
performed important epidemiological research. Pasteur travelled to the south of France 
to investigate a disease of silkworms called pébrine in research spanning five years. 
Koch travelled to Egypt and India searching for the cholera microbe and made some 
important observations about the importance of water in public health. 
 
1.8.2 Genomic epidemiology 
 
Genomic epidemiology is the application of genomic sequencing to the practice of 
disease epidemiology. Whole-genome sequencing permits phylogenetic reconstruction 
to be performed, providing an additional source of information about the relatedness of 
cases. This information has been used to determine the source of the 7th global cholera 
pandemic[41]. Originating from the Bay of Bengal analysis shows that it emerged in 
three overlapping waves. The emergence of cholera, caused by Vibrio cholerae, in Haiti 
after the 2010 earthquake resulted in 4900 deaths. Phylogenetic reconstruction showed 
isolates from the Haiti outbreak were most closely related to South Asian strains 
suggesting that Cholera had been imported to the island. After international pressure a 
UN investigation found those who had drunk contaminated water from the Artibonite 
river had become sickened. This added weight to suspicions that a UN peacekeeping 
force from Nepal were the most likely source of the outbreak as they had a camp on one 
of the river’s tributaries[42].  
  
1.9 Bioinfomatics methods 
 
 40 
1.9.1 Primary analysis 
 
Tools for primary analysis of sequence data generally fall into two categories; 
alignment (reference-based) and de novo assembly (reference-free). An underlying 
feature of both of these techniques is decomposition of sequences into k-mers, all  
possible substrings of length k contained in a string. Comparison of fixed length strings 
is extremely fast. Using shorter k-mers increases the likelihood of finding exact matches 
even in the presence of sequencing errors or biological variation. In alignment, k-mers 
are used to find alignment seeds whereas in de Brujin graph assembly the graphs are 
built from k-mers. Modern taxonomic classifiers use k-mers for fast database lookup so 
they are fundamental to bioinformatics analysis. 
 
1.9.2 Alignment 
 
1.9.2.1 Short read aligners 
 
Pairwise alignment is the comparison of two sequences, typically with DNA, RNA or 
amino acid alphabets. The first alignment algorithm and foundation for subsequent 
techniques was the Needleman-Wunsch algorithm[43]. This is able to find the best 
scoring global alignment of two whole sequences.  A development of this, the Smith-
Waterman algorithm was able to find the best local alignment i.e. a subsequence of the 
whole sequence[44]. Aligners designed for short-reads such as bwa[45], use the 
Burrows-Wheeler transform (BWT) of the reference with backward search to find 
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alignments. This technique is very efficient at aligning short reads against a large 
reference, such as human and allows mismatches and gapped alignments. 
 
Figure 7. Reproduced from[45]. A Burrows-Wheeler transform of the reference is 
generated by taking the input string ‘google’ and generating all possible rotations, 
before sorting them lexicographically and taking the last column as the output. 
 
1.9.2.2 Querying databases 
 
As of October 2017 there are over 200M sequences in GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/statistics/) and querying them quickly and 
accurately is a big challenge. It would be too slow to find the optimal match using 
Smith-Waterman so algorithms such as BLAST[46] use a hash table index to hold the 
positions of each k-mer (default k=11) subsequence in the query. It then searches the 
database for exact matches or ‘seeds’ and extends the highest scoring ones based on a 
heuristic method which is less accurate than Smith-Waterman but much faster. An 
important feature of BLAST results is the E-value, the statistical significance of the 
alignment, the lower the E-value the less likely the match is to have occurred by chance. 
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1.9.2.3 Long-read aligners 
 
Several aligners have been developed for either PacBio or nanopore long reads. They 
have typically been slower than their short-read counterparts. The exception to this is 
minimap2[47] which has designed for aligning noisy long-reads to large references. The 
algorithm uses query minimizers (reduced k-mer representations) as seeds and finds 
matches in reference minimizers. Smith-Waterman is used to extend co-linear seeds, 
called chains to generate the alignment. This approach is extremely efficient for long-
reads and achieves higher performance in terms of aligned bases per second than short-
read aligners. This is because long-reads are more likely to align uniquely, one of the 
main bottle necks in short-read alignment. 
 
1.9.3 Genome assembly 
 
Genome assembly is process of identifying overlaps in reads in order to build longer 
sequences. An early assembly method was Overlap-Layout-Consensus devised by Gene 
Myers, as utilised by the Celera Assembler. Long reads have many advantages over 
short reads for genome assembly such as their ability to span many classes of repeats. 
Assemblers for long-reads however need to be able to handle noisy reads, as both 
single-molecule platforms PacBio and Oxford Nanopore raw reads with an error rate of 
5-20%. Much of this error is random so can be averaged out using increased coverage 
resulting in more accurate consensus sequences. This however requires an all-against-all 
alignment step which is computationally expensive. In early versions of the PacBio 
assembly pipeline HGAP[48], the overlapping step accounted for 95% of the run 
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time[49]. Adam Phillippy used a probabilistic approach called MinHASH which was 
originally developed to determine the similarity of web pages to tackle the problem. The 
algorithm known as MHAP and associated assembler Canu, which is based on the 
Celera assembler achieved 10x performance improvement on smaller genomes and 
100x on larger genomes compared to previous methods. 
 
1.9.3.1 Assembly polishing 
 
Long-read assemblers such as Canu[50] will produce contigs with a similar error rate to 
the corrected reads used for the overlap-layout consensus. An additional step known as 
polishing is needed to correct short insertion, deletion and substitution errors in the 
assembly. This is done using a by aligning the original reads back to the contigs and 
calculating a consensus sequence. For PacBio assembly, Quiver[48] or Arrow is used 
which predicts the most likely consensus base using additional quality information from 
the raw reads. 
 
1.9.3.2 Error correction using Illumina data 
 
Provided sufficient coverage, long read-only assemblies will be more contiguous than 
either short-read only or hybrid assemblies. This is because hybrid assemblers typically 
use long reads for scaffolding (joining) contigs rather than for building them. After 
assembly, polishing long-read assemblies can be very accurate, with PacBio able to 
generate Q50 bacterial genomes (99.999% accurate). Despite this it is often still 
desirable to generate low coverage Illumina data for correcting the residual errors, 
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bringing the assembly up to reference quality. The E. coli K-12 genome is around 4.6 
Mb in size meaning a Q50 genome could still contain 45 errors (PacBio) or 1300 errors 
(Oxford Nanopore). In both platforms, the majority of the errors will be indels 
associated with homopolymeric tracts. These can be corrected by incorporating  
Illumina short-reads which have a mean raw read accuracy of Q20 but rarely contain 
indel errors. Pilon[51] is a tool able to generate a corrected consensus given a BAM file 
of Illumina short-reads aligned to a polished long-read assembly. 
 
1.9.4 Nanopolish 
 
Because Oxford Nanopore data differs significantly from other sequencing technologies 
a separate tool, Nanopolish is needed to calculate consensus, variant calling and 
methylation detection using the underlying signal. The first stage of the algorithm is to 
detect events, a type of partitioning used to represent the electrical current level of a 
single k-mer in the pore. The consensus algorithm iteratively proposes alternate 
consensus sequences and selects the one that maximises the probability of observing the 
events as calculated by a profile HMM. The Nanopolish HMM in consensus mode uses 
proposed consensus sequence as the backbone of the HMM with additional states and 
transitions to handle missed and split events. The method can produce a consensus 
sequence for E. coli  that is 99.97% accurate[52] with the residual error mainly 
homopolymer associated SNPs or indels, a systematic error mode in nanopore 
sequencing data. 
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Figure 8. Reproduced from http://simpsonlab.github.io/2015/04/08/eventalign/ this plot 
shows raw samples (black) and events (red) for simulated data. These can vary 
dramatically in length due to the imperfect ratcheting causing the event detector to make 
errors. 
 
1.9.4.1 Variant calling from nanopore data 
 
In order to perform variant calling, Nanopolish first infers the event to reference 
mapping for each base from the alignment of each read to the reference. Following this, 
candidate SNPs are detected by finding positions in the alignment with an alternate base 
frequency above a defined threshold (typically 20%). It then clusters these into 
haplotype groups before testing all possible haplotype combinations before calculating 
the likelihood of each using the Nanopolish HMM. Calling haplotypes rather than 
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individual SNPs improves the sensitivity of Nanopolish when calling large number of 
variants or using a divergent reference. 
 
1.9.5 Variant calling in Illumina data 
 
Variant calling using Illumina short-reads is a relatively simple procedure due to the 
high accuracy, although the shorter reads may predispose aligners to make false 
mappings. Reads are first mapped either against a closely related reference genome or 
an assembly using an aligner such as BWA[45]. Aligning to a closely related assembly 
is preferred because mapping quality and numbers increase. A goal is to be able to 
perform ‘forensic-quality’ SNP calling in order to distinguish strains which differ by as 
little as a single mutation. When variant calling groups of distantly related strains or 
strains without a closely related reference then the choice of reference genome is less 
important, but variant calls are limited to the conserved set of ‘core’ genomic regions, 
that is the ones shared by all strains. A BAM file for each sample is given to a variant 
caller such as VarScan[53] which iterates over the alignment outputting calls to a VCF 
file. Typically variant calls are filtered to improve reliability of calls using fixed criteria 
based on coverage depth, variant frequency and base or mapping quality. 
 
1.8.5.1 Functional annotation of variants 
 
To predict the effect of variants e.g. SNPs and indels, functional annotation is 
performed. The software SnpEff[54] is able to predict effects based on whether a 
mutation is; synonymous i.e. results in a codon that produces the same amino acid; non-
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synonymous i.e. results in a codon that produces a different amino acid; stop gained i.e. 
variant causes a new stop codon or frame shift i.e. an indel causes a fame shift. These 
can be assigned a severity as a synonymous change will have no phenotypic effect 
whereas a frame shift or new stop codon is likely to result in a loss of function of that 
protein. Using a VCF file input SnpEff will add predicted functional annotations to the 
information column in the VCF file.  
 
1.9.6 Bacterial annotation 
 
Identifying the various features in a bacterial genome is a process known as annotation. 
Features annotated may include coding sequences, ribosomal RNA genes and transfer 
RNA genes. Prokka[55] is a convenient pipeline which takes an input FASTA file and 
uses external tools to identify these features and combines the output into database 
compliant standard format. Protein coding sequence detection is performed using 
Prodigal[56] to identify coordinates of putative genes by identifying start and stop 
codons. These candidate genes are then searched against databases at the protein level 
to find an annotation to transfer. It does this in a hierarchical manner from most to least 
trustworthy, using the databases UniProt (most), RefSeq and Pfam (least). If no 
annotation is found gene will be labelled as hypothetical proteins. 
 
1.9.7 Tree building  
 
1.9.7.1 Tree building from variant calls 
 
 48 
Tree building software requires an input file of aligned sequences to generate a tree. 
This alignment could be a gene, core genome or just variant sites in a genome 
depending on the experiment. For basic phylogenetic inference, an approximate 
maximum likelihood tree such as that produced by FastTree is usually sufficient. 
FastTree starts with a topology produced by neighbour joining[57], a fast algorithm that 
uses a distance matrix to iteratively cluster sequences together. It then refines this 
topology using heuristics to restrict the search and estimates the rate of evolution for 
each site. Confidence in any branches are represented by bootstrap values, repeating the 
reconstruction on a subset of the data provides a way to approximate the sampling 
distribution which is unknown. Trees stored in Newick format can be visualised using 
software such as FigTree.  
 
1.9.7.2 Bayesian phylogenetic inference 
 
Bayesian phylogenetic interference relies on Bayes’ theorem to calculate the posterior 
probability given a tree and parameters. In general, the posterior probability of trees 
cannot be calculated directly as it involves high-dimensionality space of all possible 
parameter values over all possible trees. Software such as BEAST[58] uses Markov 
Chain Monte Carlo (MCMC) sampling to perform a random walk over the space. The 
number of times the algorithm visits a particular tree is proportional to the likelihood of 
that tree given the data. The chain length can be a million iterations long including a 
burn-in period which is discarded (10% by default). The algorithm is said to have 
converged or run for sufficient iterations when the trace of the posterior probability 
looks like a ‘hairy caterpillar’. An important feature of BEAST is that is can use the 
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coalescent model[59] (Figure 9) to estimate demographic function e.g. exponential 
growth and evolutionary rate from the tip dates. 
 
 
Figure 9. Figure reproduced from[60] illustrating the coalescent model. Figure shows 
the relationship of individuals samples from a constant population (a) and an 
exponentially growing population (b). As you travel back in time the probability of a 
coalescence event is inversely proportional to the population at a given time meaning 
the population size can be inferred from the pattern of coalescence and sampling events. 
 
1.9.7.3 Phylogenetic placement 
 
Phylogenetic placement is the process of placing a query sequence onto a reference 
guide tree without having to build a new tree each time. This is useful in situations 
where a) you need the result very quickly or b) have so many sequences that doing a full 
reconstruction is impractical. Pplacer[61] can place queries using either maximum-
likelihood or Bayesian mode. In maximum-likelihood mode the software evaluates the 
maximum-likelihood values across all placement locations. In Bayesian mode the 
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software evaluates the posterior probability of the new sequence being on an edge given 
the reference tree topology and branch lengths. As the reference tree is fixed the 
posterior probability can be calculated directly without the need for the MCMC 
sampling used in BEAST. Query sequences are treated independently so placement can 
be parallelised across processors. 
 
1.9.8 Taxonomic classification 
 
1.9.8.1 BLAST based classification 
 
BLAST can be used to classify sequences from metagenomic datasets by finding the 
best aligning in a database of sequences such as the NCBI non-redundant database (nr). 
Despite being able to handle large reference databases it still takes a substantial amount 
of time to process several million short reads generated by a single Illumina MiSeq run. 
MEGAN[62] uses BLAST results but improves accuracy with short reads by 
implementing a lowest common ancestor (LCA) assignment algorithm. This assigns the 
lowest node that has all the hits as descendants based on NCBI taxonomy, meaning 
species specific sequences are assigned near the leaves and conserved sequences are 
assigned near the root of the tree. You can also use MEGAN to visualise the 
composition of the community and generate trees and abundance statistics at different 
taxonomic levels. 
 
1.9.8.2 Abundance estimation software 
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Abundance estimation is general name given to classification software which achieves 
higher performance by using a reduced database which has been selected to contain 
marker sequences that identify microbial clades at species level or higher taxonomic 
levels e.g. MetaPhlAn[63]. Due to the reduced size database they only classify a small 
proportion of the dataset resulting in a relative abundance of organisms in a sample 
rather than a classification of every read. They are so much faster than BLAST based 
approaches they can scale to terabases of short read data e.g  MetaPhlAn was used to 
classify 17 million reads from the combined Human Microbiome Project (HMP)[64] 
and Metagenomics of the Human Intestinal Tract (MetaHIT)[65] datasets, 
demonstrating the first practical large-scale analysis of metagenomic datasets. 
 
1.9.8.3 k-mer based classification 
 
Kraken[66] uses an alternative approach for taxonomic assignment of reads from 
metagenomics samples. It maintains the LCA algorithm of MEGAN but uses exact k-
mer matching instead of inexact alignment which allows it to be significantly faster 
even than abundance based methods. It uses a database of k-mers and the LCA of all 
organisms whose genomes contain that k-mer, which can be built for any user-specified 
sequences but is also supplied with a default database MiniKraken DB built using k=31 
from 2,256 complete genomes downloaded from RefSeq. More recently the idea has 
been extended via the software Centrifuge[67] which incorporates an FM-index which 
is able to efficiently do exact matching of k-mers of any length rather than a fixed value 
of k. Starting at the end of the query Centrifuge finds exact matches of k=16 and 
increases k until it reaches a mismatch. Centrifuge will also output multiple 
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classifications per read, 5 by default. If there are greater than 5 high scoring 
assignments it takes the LCA of the largest group recursively, until the number of 
assignments to 5 or less. 
 
1.10 Research aims  
 
 
This work aims to further the field of genomic surveillance by introducing faster, 
cheaper and more portable methods for pathogen sequencing. Genomic surveillance 
using whole-genome sequencing has unparalleled resolution as a typing and 
epidemiological tool. Current short-read technologies require specialist facilities to 
perform sample preparation, sequencing and analysis, which can take weeks to perform. 
The introduction of nanopore sequencing in 2014 promised that it could be used to 
perform real-time, portable sequencing but it would require the development of sample 
preparation methods and analysis tools tailored to the low throughput and accuracy of 
the MinION. In this work we sought to develop and integrate new methods for sample 
preparation, sequencing and analysis to tackle viral outbreaks in the field where data 
could be made available immediately enabling more effective interventions to be made. 
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2. Seeking the source of Pseudomonas aeruginosa infections in a 
recently opened hospital: an observational study using whole-
genome sequencing 
 
2.1 Author contributions 
 
NC, CC and JQ did sequencing. JQ, NC, CMT and NJL analysed the data. NJL, NC, 
JQ, MJP and BO wrote the paper. All authors commented on the manuscript draft.  
 
2.2 Author contributions (additional detail) 
 
JQ produced the global phylogeny, the phylogenetic analysis, the sequence typing and 
the temporal/spatial analysis. JQ performed the metagenomics sequencing, taxonomic 
classification and genotyping analysis. JQ drafted all figures and assisted in writing the 
manuscript. 
 
2.3 Abstract 
 
Pseudomonas aeruginosa is an important opportunistic pathogen and a significant cause 
of morbidity and mortality. Burns patients are particularly at risk of infection due to the 
breakdown of the skin barrier. In this study patients admitted to hospital with severe 
burns had their wounds and hospital environment including the water outlets screened 
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for Pseudomonas aeruginosa. Whole-genome sequencing of 141 isolates from the study 
revealed frequent recovery of a single lineage we call ‘Clade E’ which is ST395 a 
known water associated clone. Five patients became colonised during the study period 
and in two cases the isolates recovered from the wound were indistinguishable from 
isolates recovered from water outlets from the room they were treated in. Using a near-
complete reference genome generated for this clade we performed forensic level SNP 
calling which revealed micro diversity between outlets demonstrated the power of 
surveillance sequencing of environmental isolates as a way source tracking 
Pseudomonas aeruginosa infections in a hospital environment. In one case a 
thermostatic mixer value was removed for remedial work and we performed 
metagenomic sequencing of the biofilm removed from the valve. Using a phylogenetic 
placement method we found the genotypes recovered clustered with isolates from the 
outlets in room 9 the location it had been removed from. 
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ABSTRACT
Objectives: Pseudomonas aeruginosa is a common
nosocomial pathogen responsible for significant
morbidity and mortality internationally. Patients may
become colonised or infected with P. aeruginosa after
exposure to contaminated sources within the hospital
environment. The aim of this study was to determine
whether whole-genome sequencing (WGS) can be
used to determine the source in a cohort of burns
patients at high risk of P. aeruginosa acquisition.
Study design: An observational prospective cohort
study.
Setting: Burns care ward and critical care ward in
the UK.
Participants: Patients with >7% total burns by
surface area were recruited into the study.
Methods: All patients were screened for P. aeruginosa
on admission and samples taken from their immediate
environment, including water. Screening patients who
subsequently developed a positive P. aeruginosa
microbiology result were subject to enhanced
environmental surveillance. All isolates of P. aeruginosa
were genome sequenced. Sequence analysis looked at
similarity and relatedness between isolates.
Results: WGS for 141 P. aeruginosa isolates were
obtained from patients, hospital water and the ward
environment. Phylogenetic analysis revealed eight
distinct clades, with a single clade representing the
majority of environmental isolates in the burns unit.
Isolates from three patients had identical genotypes
compared with water isolates from the same room.
There was clear clustering of water isolates by room
and outlet, allowing the source of acquisitions to be
unambiguously identified. Whole-genome shotgun
sequencing of biofilm DNA extracted from a
thermostatic mixer valve revealed this was the source
of a P. aeruginosa subpopulation previously detected
in water. In the remaining two cases there was no clear
link to the hospital environment.
Conclusions: This study reveals that WGS can be
used for source tracking of P. aeruginosa in a hospital
setting, and that acquisitions can be traced to a
specific source within a hospital ward.
INTRODUCTION
Pseudomonas aeruginosa is a ubiquitous
Gram-negative bacterium and an important
opportunistic pathogen in the healthcare
setting. P. aeruginosa particularly affects those
with impaired host or mucosal immunity and
has a broad range of presentations including
respiratory infections in cystic ﬁbrosis and
mechanically ventilated patients, bloodstream
infections in premature neonates and wounds
in burns injuries. Nosocomial P. aeruginosa
outbreaks are frequently reported and asso-
ciated with water sources such as taps,
showers, mixer valves and ﬂow straighteners,
sink traps and drains.1–10 Other potential
routes of transmission include cross-infection,
for example, carriage on the hands of health-
care workers, and through contaminated
medical equipment such as endoscopic
devices.3 5
In the UK, the role of water in the trans-
mission of P. aeruginosa in healthcare settings
has become a matter of urgent concern in
response to a recent high-proﬁle outbreak
Strengths and limitations of this study
▪ We have demonstrated that whole-genome
sequencing can be used for source tracking of
Pseudomonas aeruginosa in a hospital setting.
▪ We show convincing evidence that transmission
has occurred directly from water to patients, but
other routes are as likely.
▪ The main limitation of the study was the sample
size, which could be attributable to interventions
being carried out during the study.
▪ Our study focused on a burns unit and critical
care unit in a newly built hospital. Modes of
P. aeruginosa transmission may be different in
hospitals with different styles of plumbing and
on other augmented care units.
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affecting a neonatal critical care unit in Belfast in
2012.11 This source was eventually determined to be sink
taps.11–13 National guidance is now in place detailing
enhanced procedures for routine water sampling on
augmented care units, with directed interventions such
as disinfection and replacement of high-risk plumbing
parts required.14
Historical phenotypic typing methods for P. aeruginosa
such as O-antigen serotyping have more recently been
replaced by molecular typing methods such as pulsed-
ﬁeld gel electrophoresis (PFGE), variable number
tandem repeat analysis, random ampliﬁcation of poly-
morphic DNA and multilocus sequencing typing
(MLST).15 These methods have been used to investigate
outbreaks of P. aeruginosa within hospitals.4 16–18
However, such techniques have important limitations for
source tracking of infections in hospitals as they sample
limited numbers of sites in the genome which may
result in false clustering of unrelated strains.19 In the
past 5 years, whole-genome sequencing (WGS) has
started to be used to investigate outbreaks in hospitals.
WGS is attractive because of its digital, sharable format
and ultra-high resolution, which is able to discriminate
two isolates differing by just a single mutation. WGS has
been successfully used to determine likely transmission
chains during outbreaks of Staphylococcus aureus,
Acinetobacter baumannii and Klebsiella pneumoniae.19–21
Benchtop sequencing instruments now offer a cost-
effective approach for bringing bacterial WGS to the
clinical environment.22
In this study, we explore the utility of WGS to deter-
mine the likely sources of P. aeruginosa in an at-risk
population of burns patients. In the UK and US burns
patients receive shower cart hydrotherapy as a mainstay
of burns treatment.23–26 A previous hospital audit sug-
gested that up to one-third of such patients became
colonised with P. aeruginosa. We hypothesised that this
high rate of acquisition may relate to transmission from
hospital shower water during therapy. We therefore
wished to understand the importance of transmission
from water compared with alternative routes such as
cross-infection and endogenous carriage.
MATERIALS AND METHODS
Hospital setting
An observational, prospective study design was employed
in a burns centre serving approximately 13.7 million
people across the Midlands region of England with 300
admissions annually. Opened in June 2010, the burns
centre comprises a purpose built 15-bed ward with 11
side-rooms and 2 dual-bedded rooms. Patients requiring
mechanical ventilation and organ support are usually
treated in two self-contained burns cubicles located
within the trauma critical care unit. Despite the observa-
tional nature of the study, sampling was carried out
during implementation of interim national guidance on
control of P. aeruginosa issued by the Department of
Health. These guidelines were issued in draft form
March 2012, and subsequently revised in March 2013.
This meant that parallel water sampling and engineering
interventions were being undertaken during the period
of study. In addition, some enhanced infection preven-
tion measures were also introduced in response to an
outbreak of a multidrug-resistant A. baumannii.
Study design and patient selection
Patients admitted to the burns unit were eligible for the
screening phase of the study if they had burns injuries
covering greater than 7% total body surface area
(TBSA). Patients were screened as soon as possible after
admission after they had given written informed
consent. When appropriate, legal consultee advice was
sought for patients lacking capacity due to emergency
treatment. On admission, recruited patients were
screened for carriage of P. aeruginosa (wounds, urine
and stool) using standard microbiology techniques.
Samples were then taken as part of routine microbiology
service during the patients stay. Environmental and
water samples were taken after the patient was admitted
to the burns centre. If during the period of stay P. aerugi-
nosa was isolated from a patient sample the patient was
recruited into the second phase of the study. In this
phase, patients had wound swabs taken at each dressing
change as well as twice-weekly urine samples. The
patient’s environment and water from outlets in their
bed space were sampled weekly for the duration of their
stay, and after discharge (post-cleaning). Termination of
the study was planned after 30 screening patient admis-
sions, or a year, whichever came soonest, after which 10
patients were expected to acquire P. aeruginosa. This pre-
diction was based on a previous local audit which sug-
gested about one-thirds of burns patients became
colonised with P. aeruginosa.
Microbiological and molecular methods
P. aeruginosa isolates were obtained from wound swab,
urine, stool, environmental and water samples. P. aerugi-
nosa was isolated from wound swabs, urine and stool by
inoculation onto cysteine lactose electrolyte deﬁcient
agar (CLED) and cetrimide agar and incubation for 24 h
at 37°C. Stool samples were cultured overnight in a cetri-
mide enrichment broth before subculture onto CLED.
Identiﬁcation was conﬁrmed by resistance to C-390 and
the VITEK 2 GN identiﬁcation card. Antibiotic sensitivity
assays were performed using the VITEK 2 AST N-210
card (bioMérieux, Basingstoke, UK).
The patient’s environment (shower head rosette,
drain, shower chair or trolley, bedside table, patient
chair, instruments in contact with the patient) was
sampled over a 10 cm2 area by a Polywipe sponge. The
sponge was placed in tryptic soy broth incubated for
24 h at 37°C then subcultured onto CLED and cetrimide
agar. During water sampling, water was taken from the
patient’s shower, or tap if a shower was not present.
Shower heads were not removed for water sampling. At
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least 200 mL of water was collected into a vessel contain-
ing sodium thiosulfate as a neutraliser. In duplicate,
100 mL of water was ﬁltered through a 0.45 µ ﬁlter and
the ﬁlters placed onto CLED plates and cetrimide agar.
Plates were incubated at 37°C for 48 h and the number
of organisms per 100 mL quantiﬁed.
For storage and DNA extraction a single colony was
puriﬁed from the primary culture plate. When different
colony morphologies were observed, a single colony
from each type was puriﬁed. Additionally, for a randomly
selected water sample, 24 colonies were individually
picked from one water-ﬁlter primary microbiological
plate for sequencing. Isolates were stored on Biobank
beads at −20°C prior to DNA extraction. Organisms
were resuscitated on CLED agar plates and genome
DNA either extracted directly using the MOBIO
UltraClean Microbial DNA Kit, or from overnight LB
broth culture using a Qiagen Genomic-Tip 100G.
DNA extraction and sequencing
Genomic DNA was prepared from single colony picks
using the MOBIO Ultraclean microbial kit (MOBIO,
Carlsbad, USA). 1 ng input DNA, as quantiﬁed by Qubit
(Life Technologies, Carlsbad, USA) was used to prepare
genomic libraries for sequencing using the Illumina
Nextera XT DNA sample kit as per manufacturer’s proto-
col (Illumina, San Diego, USA). Libraries were
sequenced on the Illumina MiSeq using a paired-end
protocol resulting in read lengths between 150 and 300
bases. A single additional sample, isolate 910, was chosen
as a representative member of Clade 5 for long-read
sequencing. DNA from this sample was fragmented using
a Hydroshear (Digilab, Marlborough, Massachusetts,
USA) using the recommended protocol for 10 kb frag-
ments and further size-selected on a BluePippin instru-
ment (Sage Science, Massachusetts, USA) with a 7 kb
minimum size cut-off. The library was sequenced on two
SMRT Cells using the Paciﬁc Biosciences RS II instru-
ment at the Norwegian Sequencing Centre, Oslo. C4-P2
chemistry was chosen because it favours long, more accur-
ate reads for de novo assembly.
Stool PCR
For simple presence/absence detection of P. aeruginosa
in stool samples using PCR, a stool sample was collected
into a stool collection tube containing stool DNA stabil-
iser. Total DNA was extracted using the PSP Spin Stool
DNA Plus kit (Stratec Molecular). PCR ampliﬁcation of
species speciﬁc regions of the 16S rDNA gene was
carried out using primers PA-SS-F: GGGGGATCTTCG
GACCTCA and PA-SS-R: TCCTTAGAGTGCCCACCCG 12
in the following conditions: 0.5 µM of each primer,
1.5 mM MgCl2, 0.2 mM dNTP’s using BIOTAQ DNA
Polymerase and buffer set. After initial denaturation at
96°C for 2 min, 30 cycles of 96°C for 30 s, 62°C for 30 s
and 72°C for 30 s were completed with a ﬁnal extension
of 72°C for 5 min. Products were visualised for size on
an 1.5% agarose gel.
Bioinformatics methods
Illumina MiSeq reads from each isolate were adapter
and quality trimmed before use with Trimmomatic.27
Phylogenetic reconstruction of isolates sequenced in this
study were combined with data from a global collection
of 55 P. aeruginosa strains collected world-wide which
have been previously analysed by Stewart et al.28 For each
of the published strains, 600 000 paired-end reads of
length 250 bases were simulated using wgsim (https://
github.com/lh3/wgsim) from the complete or draft
genome assembly deposited in Genbank. Read sets were
mapped against the P. aeruginosa PAO1 reference
genome using BWA-MEM 0.7.5a-r405 using default set-
tings.29 Single nucleotide polymorphisms were called
using VarScan 2.3.6 and ﬁltered for regions with an
excessive number of variants. These may represent
regions of recombination, misalignments or strong
Darwinian selection.30 FastTree (V2.1.7) was used for
phylogenetic reconstruction. This software estimates an
approximate maximum-likelihood tree under the
Jukes-Cantor model of nucleotide evolution with a single
rate for each site (CAT).31 Trees were drawn in FigTree
(http://tree.bio.ed.ac.uk/software/ﬁgtree/).
For in silico MLST prediction, trimmed reads were
assembled de novo using Velvet 32 with a k-mer size of 81
and searched using nucleotide BLAST against the multi-
locus sequence database downloaded from the pubMLST
website on 5 August 2013 (http://pubmlst.org/
paeruginosa/).33 For Clade E isolates, in order to
exhaustively search for discriminatory mutations, a nearly
complete reference genome was generated by de novo
assembly using Paciﬁc Biosciences sequencing data.
Reads were assembled using the ‘RS_HGAP_Assembly.3’
pipeline within SMRT Portal V2.2.0. Illumina reads from
the same sample were mapped to this draft genome
assembly in order to correct remaining indel errors in
the assembly using Pilon (http://www.broadinstitute.
org/software/pilon/). Isolates belonging to each clade
were mapped individually against either the PacBio refer-
ence (Clade E) or P. aeruginosa PAO1 (NC_002516;
Clades C, D and G).
Variants (single nucleotide polymorphisms and short
insertion-deletions) were called using SAMtools mpileup
and VarScan with an allele frequency threshold of 80%.30
Non-informative positions and regions of putative recom-
bination were removed, the later with a variant density
ﬁlter of more than 3 SNPs every 1000 nucleotides.
Analysing samples in each clade individually maximised
the number of variants detected by reducing the likeli-
hood of the position being uncovered by a subset of
samples. From these variants ﬁne-grained phylogenetic
trees were reconstructed for each clade using FastTree.
The scripts used to perform this analysis are available
at http://www.github.com/joshquick/snp_calling_scripts.
Approximate-maximum-likelihood phylogenetic trees
were generated using FastTree and visualised in FigTree.
For whole-genome shotgun metagenomics analysis, reads
were analysed using the Kraken taxonomic classiﬁer
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software with the supplied minikraken database.34 Reads
from the metagenomics data set were aligned to P. aerugi-
nosa Clade E as in the previous section and phylogenetic
placement was carried out using pplacer in conjunction
with FastTree.35 Sequence data is available from the
European Nucleotide Archive for the Illumina data
(ERP006056) and the corrected Paciﬁc Biosciences
assembly (ERP006058).
RESULTS
Study results
Recruitment lasted a period of 300 days, ending accord-
ing to protocol after the enrolment of 30 screening
patients. In total, we detected P. aeruginosa in ﬁve
patients. Of these patients, three had P. aeruginosa
detected only in burns wound swabs, one had P. aerugi-
nosa detected in their burns wound and in their urine,
and one had P. aeruginosa in their sputum. One add-
itional eligible patient did not consent to enter the study
and was excluded. The average age in the study group
was 41 years. Males predominated with a male-to-female
ration of 2.3:1. Flame burns were the most common
mechanism of injury, followed by scalds and mixed
ﬂame/ﬂash injuries. The average burn size of the study
group was 12.5% of the TBSA and 27% of patients sus-
tained an inhalation injury. Eight patients required
admission to intensive trauma unit (ITU) and the major-
ity required surgical treatment of their burns with exci-
sion and skin grafting (80%). A large majority of the
study group (83%) received shower cart hydrotherapy as
a routine part of their wound management to encour-
age healing through wound debridement and decon-
tamination. The average length of hospital stay (LOS)
was 17 days and taking into account burn size, the
average was 1.4 days per % TBSA.
The water and environment in burns and critical care units
are frequently colonised by P. aeruginosa
A total of 282 water and environmental samples were
screened for P. aeruginosa of which 39/78 (50%) were
positive in water samples, 25/96 (26%) were positive
from the wet environment and 7/108 (6%) were positive
from the dry environment. A total of 86 genome
sequences were generated from the 71 positives, as in
some cases multiple colony picks were sequenced.
Seventy-eight patient samples were screened for P. aerugi-
nosa of which 39 (50%) were positive. A total of 55
genome sequences were generated, as in some cases
multiple colony picks were sequenced. In total, 141
genomes were sequenced; water and environmental
(n=86) and patient (n=55). Genomes were sequenced to
a mean coverage of 24.4×, with the minimum coverage
of a sample being 14× and highest 64.7×.
When placed in the context of a global collection of
P. aeruginosa strains, phylogenetic reconstruction demon-
strated isolates in our study fell into eight clades (ﬁgure
1A). As has been reported previously, there was no
strong association between ecological context and pos-
ition in the phylogenetic tree.28 Isolates in this study are
most closely related to strains from a variety of settings.
The majority of isolates (52%) belong to Clade E
(ﬁgure 1B), whose nearest sequenced relative is the
Liverpool Epidemic Strain, a clone often isolated from
patients in the UK and Canada with cystic ﬁbrosis. 36 37
Isolates from Clade E were found in the burns unit’s
water and the ward environment, as well as from two
patient’s wounds. However it was never detected in the
critical care unit. Clade E was detected throughout the
study in a total of 10 different rooms (ﬁgure 2).
Inferring potential transmission events by WGS
Microevolutionary changes occurring over rapid time-
scales (ie, days to months) have been used to detect
potential chains of transmission in hospital and commu-
nity outbreaks.19–21 38 39 The number of distinct muta-
tions between given isolates has been used to infer
whether transmission events are likely to have occurred.
Such inferences are aided by prior knowledge of muta-
tion rates in similar populations. Two patients (1 and 4)
in our study both had P. aeruginosa from Clade E isolated
from their wounds. These isolates had an indistinguish-
able genotype from those present in water and the envir-
onment of the room they were nursed within (ﬁgures
1C and 3). This genotype was detected in the patient’s
shower water after initial patient screening, during
screening of the second patient admission, twice during
the second patient’s stay and then 127 days later (days
27, 65, 89 and 216, respectively). When water isolates
were positive, the genotype was also detected in wet
environment sites (shower drain, shower rosette and
patient’s trolley) on the same days.
Patient 5 was nursed on the critical care unit due to
concomitant medical problems. P. aeruginosa belonging
to Clade G was isolated from sputum during this time.
Identical genotypes were detected contemporaneously
in the water from the associated sink and sink tap
handle (see online supplementary appendix 4).
Two further patients (patients 2 and 3) were positive
for P. aeruginosa. Isolates from these patients belonged to
Clade C and D, respectively. Neither clade was ever iso-
lated from hospital water. In both cases, identical geno-
types were detectable in the environment associated
with the patient but these were not detected before or
after the patients’ stay, indicating that the environment
was not persistently contaminated. During the course of
patient 3’s stay, the dry environment such as the bedside
table was contaminated, as was the patient’s door handle
and shower chair. However, after patient discharge, the
strain associated with this patient was never seen again
during the course of the study in any location.
WGS permits source tracking of P. aeruginosa to
individual water outlets
WGS has been reported previously for source tracking,
but never for the detection of transmission events from
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hospital water.40 Phylogenetic reconstruction within
Clade E, the most commonly detected water clone
demonstrated additional diversity within this clone, with
a total of 46 mutations detected an average genetic dis-
tance between isolates of 4.1 mutations (ﬁgure 3). The
reconstruction demonstrated clear evidence of cluster-
ing of genotypes both by room and outlet (ﬁgure 3).
When P. aeruginosa was detected in the wet environment
(eg, shower rosettes and drains) these genotypes were
most often identical to those found in water, indicating
that the water was likely the ultimate source of that
clone. Genotypic variation was seen between outlets
within the same room. For example, tap water sampled
from room 11 had a distinct genotype from that
sampled from shower water in the same room and this
was consistently found over multiple samplings. Notably,
isolates from two patients fell within the cluster originat-
ing from shower water, indicating that shower hydrother-
apy was the most likely source of infection. Two plasmids
(designated pBURNS1 and pBURNS2) were detected in
this study set, which both demonstrated geographical
clustering, with pBURNS1 only being detectable in iso-
lates from room 8 and pBURNS2 only being detectable
in isolates from the shower water in room 9.
Rapid evolution of antibiotic resistance associated with
treatment
P. aeruginosa is commonly associated with antibiotic
resistance due to a number of predisposing features
including intrinsic resistance, a repertoire of efﬂux
pumps and antibiotic-inactivating enzymes including
β-lactamases.41 Three infected patients (2, 3 and 5)
received antibiotic therapy, and in each case this was
associated with the development of resistance to at least
one therapeutic agent. Associated mutations were
detected that were either partially or fully explanatory of
the phenotype (online supplementary appendix 12).
Patient 2 was treated with ciproﬂoxacin, nitrofurantoin
and vancomycin (see online supplementary appendix 11
for full details). Eight of 21 (38%) tested isolates from
this patient were ciproﬂoxacin resistant. Seven of eight
isolates (88%) of the ciproﬂoxacin-resistant strains were
distinguishable from the other isolates by a single SNP in
mexS (annotated as PA2491 in P. aeruginosa PAO1; see
online supplementary appendix 1 and 7). This SNP was
predicted to result in a non-synonymous amino acid sub-
stitution. Disruption of this gene has been shown to
cause increased expression of the mexEF-oprN multidrug
efﬂux pump, associated with resistance to quinolones.42
Figure 1 An overview of all samples collected during the study in global phylogenetic context with other sequenced strains of
Pseudomonas aeruginosa from the set of Stewart et al.28 Samples collected in this study are widely dispersed in the tree, which
contains isolates from different environments (A). Bar plots indicate the numbers of each type of sample collected (B).
Microdiversity within each clade is shown, with the colour bar indicating the source of each sample (C).
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Patient 3 was not treated with antibiotics, but isolates
associated with this patient demonstrated differences in
resistance to timentin and piperacillin-tazobactam. These
changes were associated with non-synonymous mutations
in gacA, the response regulator of the GacA/GacS two-
component system and in lasR, a transcriptional activator
required for transcription of elastase and LasA protease
(online supplementary appendices 2 and 8).
Patient 4 was treated with meropenem, piperacillin/
tazobactam, ﬂucloxacillin and colistin. Five isolates col-
lected 10–18 days after initiation of meropenem showed
resistance to imipenem and intermediate resistance to
meropenem (see online supplementary appendix 3 and
9). The most likely mutation responsible for this pheno-
type was detectable in two isolates, both of which had a
frame-shift mutation in the gene coding for the mem-
brane porin OprD.43
Patient 5 had a prolonged stay in ITU and had mul-
tiple medical problems including A. baumannii infection
and was treated with nine antibiotic agents including
ciproﬂoxacin, meropenem and piperacillin-tazobactam.
Serial isolates from this patient demonstrated the
stepwise acquisition of two mutations (online
supplementary appendix 4). The ﬁrst was in nalC, a
probable repressor of the TetR/AcrR family (online
supplementary appendix 10).44 On inspection of the
sequence alignment in this region, a large deletion of
196 nucleotide bases was seen compared to the refer-
ence PAO1 strain. This mutation was seen in association
with full resistance to piperacillin-tazobactam, ceftazi-
dine, aztreonam, meropenem and intermediate resist-
ance to ciproﬂoxacin. This deletion is likely to result in
over-expression of efﬂux pumps involving the
mexAB-oprM operon.44 45 Ciproﬂoxacin resistance in a
later isolate corresponded to the stepwise acquisition of
a second mutation. This mutation is predicted to affect
the well-studied DNA gyrase subunit A gene (gyrA)
which is strongly associated with ciproﬂoxacin
resistance.46
Confirmation of P. aeruginosa genotypes in biofilms by
whole-genome metagenomic shotgun sequencing
P. aeruginosa is able to produce and survive in bioﬁlms.
Plumbing parts such as ﬂow straighteners, shower rosettes,
Figure 2 A schematic view of the 300-day study of Pseudomonas aeruginosa in a burns centre and critical care unit. Time in
days is shown along the x axis with bed numbers in the critical care unit and burns unit along the y axis. Each circular icon
indicates a positive isolate of P. aeruginosa. The icon’s logotype indicates which environment it originated from (wound, urine/
sputum, environment or water). The filled colour of the icon indicates the clade it belongs to. Patient icons represent the
enrolment of a screening patient into the study and their location. Patient movements around the hospital are noted by dotted
lines. The five patients infected with P. aeruginosa are denoted by rounded boxes. Boxes are coloured according to the patient
number. In the event two or more isolates of the same source and clade were collected on the same day, these have been
collapsed into a single circular icon.
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ﬂexible hoses, solenoid valves and thermostatic mixer
valves (TMV) are particularly at risk of bioﬁlm formation
due to factors including surface areas, convoluted designs
and inadequate pasteurisation.47 To conﬁrm the presence
of P. aeruginosa in water ﬁttings associated with rooms on
the burns unit, we obtained a TMV removed by the hos-
pital estates team from the shower in room nine as part of
compliance with UK guidelines for managing P. aeruginosa
in hospitals. On visual inspection, a bioﬁlm was present
which was scraped from the surface with a sterile scalpel.
DNA from this bioﬁlm was extracted for whole-genome
shotgun sequencing. The majority of reads did not map to
any known bacterial taxa. The most abundant taxon identi-
ﬁed was P. aeruginosa (3%). Subsequent alignment to the P.
aeruginosa Clade E reference covered 94% of the 6.3
million base reference genome at a median coverage of
Figure 3 The high-resolution phylogenetic reconstruction of Clade E isolates. This demonstrates the clustering of genotypes by
bed space. Patient associated samples are contained within a room 11 clade. This clade contains water samples from the
shower and environmental samples from the shower, drain and trolley. The water samples from the room 11 tap are in a distinct
clade, indicating the biofilm within the tap has a distinct genotype to the shower. This suggests environmental contamination was
more likely to arise from contaminated shower water than tap water. Details of sampling site, days since start of study and
presence of pBURNS plasmids are also shown. The likely phylogenetic position of Pseudomonas aeruginosa detected in a
biofilm from a thermostatic mixer valve is shown in the clade associated with room 9 and indicated ‘TMV’.
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5×, conﬁrming that reads were correctly classiﬁed to this
species and not other environmental Pseudomonas species.
Alignment to the P. aeruginosa Clade E reference genome
followed by phylogenetic placement of reads demonstrated
that it fell into the same clade as previously recovered iso-
lates from the shower or tap in room 9 (indicated on
ﬁgure 3, and in online supplementary appendix 6).
DISCUSSION
The hospital environment has been intimately linked
with P. aeruginosa infection for over 50 years yet hospital
acquisitions, clusters and outbreaks remain a common
occurrence and understanding precise routes of trans-
mission can be difﬁcult.47 48 Our results demonstrate
that, even in a new hospital, P. aeruginosa can become
rapidly endemic in hospital plumbing. Furthermore, by
linking P. aeruginosa genotypes recovered from patients
to speciﬁc individual water outlets, we offer compelling
evidence of unidirectional transmission from water to
patients. Further, by sequencing of a bioﬁlm identiﬁed
in a TMV from a hospital water system, we can identify
the likely common source of genotypes found in water
and in the hospital environment.
Our results suggest that use of WGS can reduce ambi-
guity about potential transmission events in hospitals
and consequently inform infection prevention efforts
about the direction and sequence of transmission.
Typing schemes such as MLST and PFGE are much
lower resolution methods and would not be able to
provide sufﬁcient information to permit such inferences
to be made. It is notable that the burns unit was colo-
nised by a single clone, meaning that it was very unlikely
that water outlets at each bed space were colonised as a
result of transmissions from the patient or environment.
For this to happen would require multiple transmission
events from separate patients with the same clone, for
which there is no evidence. Instead we speculate that
this clone was introduced to the hospital associated with
its commissioning. One hypothesis is that particular
plumbing ﬁttings, that is, the TMV may have been colo-
nised simultaneously by a clone circulating in water.
Clade E (ST395) has been frequently reported asso-
ciated with water, so this remains a possibility. 49 50
However, it is possible that plumbing ﬁttings are
installed ‘pre-seeded’ with P. aeruginosa as has already
been proposed by Kelsey.3 5 47 Investigation of an out-
break in Wales implicated new plumbing parts as a
potential source of P. aeruginosa. New plumbing compo-
nents are often tested by companies prior to their
supply and it is possible they were contaminated prior to
distribution. The limited amount of diversity (average 4
SNPs) seen within this clade is consistent with a single
founding genotype coinciding with the opening of the
burns unit, based on estimates from a previous study
using WGS which reported that mutations accumulate at
a rate of approximately one every 3–4 months in a
hospital-associated clone.51 However, our results suggest
that our isolates accumulate mutations even more slowly.
This may be due to reduced growth rates in
nutritionally-poor bioﬁlms.52
It is notable that antibiotic resistance to multiple ﬁrst-
line agents developed rapidly in response to therapy.
These results underline the importance of selecting appro-
priate antibiotic therapy in P. aeruginosa infections. It is
reassuring however that antibiotic resistance genotypes
selected in vivo did not show evidence of persistence in the
ward environment or transmission to other patients.
Our study has certain limitations. Based on a previous
audit, we expected around one-third of patients
screened for P. aeruginosa would develop colonisation or
clinical infection. In fact, only 5 out of 30 of patients
were colonised. This may have been related to guidance
and engineering interventions being put in place during
the study as detailed in national guidance issued while
this study was on-going. In addition, infection control
policies were revised to address control of an outbreak
of a multidrug resistant A. baumannii in this same burns
unit. Following these interventions, only 1 of the last 20
patients recruited was infected with P. aeruginosa which
may demonstrate the importance of national guidance
in reducing transmissions.
By focusing on burns patients who receive hydrother-
apy, our study population were at extremely high risk of
waterborne infection. In other patient groups it may be
that alternative routes of transmission including cross-
infection or endogenous carriage play a more important
role. Our results suggest that our burns unit is endemic-
ally colonised with a distinct clone of P. aeruginosa that
may have been imported coinciding with the opening of
the hospital. Other intensive care units, particularly
those which have been open for longer may harbour a
greater diversity of P. aeruginosa as a result of increased
opportunities for clones to be imported.
One potential application for WGS in infection
control would be to determine whether cases are as a
result of water transmission, or represent sporadic
clones originating from the wider environment. Despite
improved guidance concerning improved engineering
infection control practices and the introduction of the
water safety group in the UK, it may not be realistic to
eliminate P. aeruginosa from hospitals entirely. In aug-
mented care units such as ITUs, burns units and neo-
natal wards where P. aeruginosa poses a signiﬁcant risk to
vulnerable patients, the increased resolution offered by
WGS will justify its use, particularly as the costs continue
to fall.
In conclusion, we have identiﬁed through WGS clear
evidence for transmission of P. aeruginosa from speciﬁc
water outlets to burns patients and offer a forensic-level
framework for dealing with outbreaks linked to hospital
water. We expect WGS will continue to make inroads
into clinical microbiology and become a vital tool for
tracking P. aeruginosa in the hospital environment,
helping inform targeted control measures to help
protect patients at risk of infection.
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3 Rapid draft sequencing and real-time nanopore sequencing in a 
hospital outbreak of Salmonella 
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wrote the scripts to perform the streamed genotyping and the pplacer analysis. JQ 
drafted figures, tables and contributed to the writing of the manuscript. 
 
3.3 Abstract 
 
In this study we investigated the use of both the MiSeq and the MinION to provide 
clinically relevant information during an ongoing local hospital outbreak of Salmonella 
enterica Serovar Enteritidis. During the outbreak we sequenced 16 isolates using a 6 
hour MiSeq ‘draft sequencing’ protocol we developed to quickly rule isolates in or out 
of the outbreak. Later we sequenced two isolates on the MinION, one known to be from 
 56 
the outbreak and one not. In order to simulate real-time data, the reads were analysed as 
they would have become available in real time i.e. at ten minute intervals after the start 
of the run. We demonstrated two new analysis approaches; the first able to 
unambiguously identify the species as Salmonella enterica within 30 minutes and the 
second able to assign one sample to the main hospital cluster within 100 minutes and 
the other to a different cluster containing a mixture of phage types none of which were 
the same as the hospital cluster (14b) within 120 minutes. Surveillance sequencing of 
foodborne pathogens is an exciting development pioneered by the Food and Drug 
Administration (FDA)[68] and Public Health England (PHE). Integrating our data with 
these resources allowed us to place the outbreak in a national and international context. 
 
3.4 Published manuscript 
 
  
RESEARCH Open Access
Rapid draft sequencing and real-time nanopore
sequencing in a hospital outbreak of Salmonella
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Abstract
Background:Foodborne outbreaks of Salmonella remain a pressing public health concern. We recently detected a
large outbreak of Salmonella enterica serovar Enteritidis phage type 14b affecting more than 30 patients in our
hospital. This outbreak was linked to community, national and European-wide cases. Hospital patients with
Salmonella are at high risk, and require a rapid response. We initially investigated this outbreak by whole-genome
sequencing using a novel rapid protocol on the Illumina MiSeq; we then integrated these data with whole-genome
data from surveillance sequencing, thereby placing the outbreak in a national context. Additionally, we investigated
the potential of a newly released sequencing technology, the MinION from Oxford Nanopore Technologies, in the
management of a hospital outbreak of Salmonella.
Results:We demonstrate that rapid MiSeq sequencing can reduce the time to answer compared to the standard
sequencing protocol with no impact on the results. We show, for the first time, that the MinION can acquire
clinically relevant information in real time and within minutes of a DNA library being loaded. MinION sequencing
permits confident assignment to species level within 20 min. Using a novel streaming phylogenetic placement
method samples can be assigned to a serotype in 40 min and determined to be part of the outbreak in less than
2 h.
Conclusions:Both approaches yielded reliable and actionable clinical information on the Salmonella outbreak in
less than half a day. The rapid availability of such information may facilitate more informed epidemiological
investigations and influence infection control practices.
Background
Outbreaks of Salmonella from contaminated food are
frequently reported in the community, with 1.2 million
cases estimated to occur in the US each year [1]. In a
population-based study in the UK in 2008–2009, there
were >38,600 estimated cases of salmonellosis and
11,300 patients presenting to a primary care physician
[2]. Hospital outbreaks of Salmonella may result from
patient-to-patient spread and can be lethal in vulnerable
patients [3–5]. An example is the hospital outbreak at
Stanley Royd Hospital in the UK which led to the deaths
of 19 patients and a public inquiry [2, 6]. We recently
detected a cluster of more than 30 cases of Salmonella
enterica serovar Enteritidis (S. Enteritidis) over a 3-week
period at one of three hospital sites in our hospital or-
ganisation and from the community. This was against a
typical background incidence of five to eight cases per
month of all S. enterica isolates in the area served by
our hospital. Initially a small number of seemingly unre-
lated, presumed community-acquired cases were de-
tected on different wards but subsequently a larger
number of long-term inpatients on two adjoining wards
were affected suggesting the possibility of spread within
the hospital. Simultaneously, an increase in community
isolates was also detected. At first, it was unclear
whether hospital cases were reflecting multiple imports
from a community outbreak or spread within the hos-
pital or both. Due to the explosive nature of the out-
break, coupled with uncertainty about the source, a
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rapid response was required to ensure that infection
control measures were appropriately targeted. Outbreak
investigations are aided by rapid availability of whole-
genome sequencing (WGS) data, as this provides the
greatest level of discrimination between isolates when
compared to traditional typing methods such as phage
typing, multilocus variable number tandem repeat ana-
lysis (MLVA) and pulsed-field gel electrophoresis (PFGE)
[3–5, 7]. The Illumina MiSeq sequencing platform has
emerged as the gold standard for WGS investigations of
outbreaks, but results may not be available for as long as
3 working days, depending on the protocol used [8–10].
A number of studies have evaluated the utility of WGS
for typing S. enterica isolates; however, to the authors’
knowledge, this is the first use of prospective typing of
this organism during an outbreak. Rapid availability of
accurate typing results is critical to effective outbreak
control. We therefore devised a novel rapid draft se-
quencing protocol on the MiSeq generating results in
under 6 h following library preparation. At the time of
the outbreak we were testing a portable, handheld, ‘USB
stick’, whole-genome sequencer, the MinION (Oxford
Nanopore Technologies, UK), as part of their early
access programme. We wished to see what role this
technology might play in the management of future
outbreaks.
Our initial goals when performing sequencing pro-
spectively were: (1) to determine if cases in the hospital
were from the same strain as those circulating in the
community, and to discriminate outbreak cases from
normal background S. enterica strains; (2) to determine
whether there was evidence of a super-shedder patient
or specific breakdown in infection control practices; (3)
to help link cases to a primary source (for example, per-
son or food) and to compare to previous outbreak
strains; and (4) to integrate these results with national
surveillance data.
Results and discussion
Epidemiological investigation
In total, 43 isolates of S. Enteritidis were identified in the
study period (1 to 24 June) from inpatients, community
samples from general practitioners and from environmen-
tal isolates. Hospitalised cases were only identified at one
hospital site in the group of three hospitals. The same hos-
pital food is distributed to all three hospital sites from a
single, central kitchen processing unit where hot food is
twice-cooked to standards that would kill salmonellae. All
microbiological testing of hospital food was negative for
Salmonella. The environmental swabs from affected wards
were all negative apart from one isolate of S. Enteritidis re-
covered from the outside door seal of a food regeneration
trolley. This proved to be of the outbreak type. Four separ-
ate colony picks were sequenced from this culture. Isolates
from staff were sent to the reference laboratory by another
laboratory in a different city 14 miles away. These were
detected in faecal samples submitted by general practi-
tioners and were found to belong to staff at our hospital
working on the affected wards. The first 16 samples, of
which six cases had onset dates compatible with commu-
nity acquisition, were available for sequencing on 10 June
and 13 samples sequenced successfully. These were subse-
quently shown to be distinct from other isolates recently
sequenced by national surveillance and were identical to
each other, apart from three cases that each had one SNP
difference (Fig. 1, Panel a).
Sequencing of isolates from two early patient cases on
3 and 4 June showed them to be identical. As both pa-
tients had been hospitalised for longer than the Salmon-
ella incubation period this was strongly suggestive of
hospital acquisition. There were nine other cases on or
prior to 4 June, which together with the typing data
helped to inform further infection control actions. All
symptomatic patients were isolated and the two wards
were closed. Deep cleaning was undertaken with
vaporised hydrogen peroxide sterilisation. Four isolates
from the later part of the outbreak were identified by
SNP typing to be unrelated to the outbreak type. Two of
the four isolates were from young children who had re-
cently returned from separate holidays in Egypt. These
isolates were different to each other but one was identi-
cal to another isolate from a child of similar age who
had not travelled abroad, which prompted further epi-
demiological investigation. It emerged that the two chil-
dren attended the same nursery in a town just outside
the city in which the hospital outbreak had been de-
tected, strongly suggesting transmission had occurred
within the nursery (Fig. 1).
The earliest date of onset was 25 May and the last 8
July. A total of 37 cases with the outbreak strain were
identified of which six had no connection with the hos-
pital, eight were staff members and three were asymp-
tomatic carriers identified by screening patients on
outbreak wards. Comparison of the outbreak genome se-
quence with the Public Health England database of
strains from the whole of England and Wales suggested
a very close relationship to six isolates from London,
Bedford and Northampton. Further epidemiological in-
vestigation of these cases found no link to Birmingham
or a foodstuff. The outbreak strain was PT 14b and
multi-locus variable number tandem repeat (MLVA) type
2-11-9-7-4-3-2-8-9, an uncommon type for PT 14b
strains.
Rapid draft sequencing on the Illumina MiSeq
As an initial response to the outbreak, isolates from 16
patients were sequenced overnight on the Illumina
MiSeq on 12 June 2014 in order to generate results for
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an infection control meeting the following day (results
shown in Fig. 1 Panel a). To enable this, we devised a
new draft sequencing protocol that reduced the run time
of the MiSeq instrument to 6 h (contrasted with stand-
ard protocols which can take up to 55 h to complete).
This was achieved by reducing the read length, cycle
time and number of tiles imaged. Of the 16 isolates, 13
had a mean coverage depth of greater than 4× (mean
8×) and could be used for further analysis. Due to the
lower coverage of strains, 50.2 % of the core genome
was used to generate these results. Despite this, the re-
sults generated within 6 h were sufficient to conclude
that the initial set of isolates were all part of the same
outbreak (10/13 isolates were identical when analysing
the core genome of S. Enteritidis, three other isolates
each differed by 1 SNP). Later on, when standard proto-
col MiSeq (paired 250 or 300 bp) data were available as
well as HiSeq data from PHE surveillance, we were able
to compare these results to that of draft sequencing. We
could then conclude that although genome coverage was
lower, the rapid draft sequencing method was concord-
ant with both slower methods (Fig. 1). The sequencing
quality using the draft protocol was lower (median Q
score 36 compared with 38 using the V2 and V3 proto-
cols at cycle 75) (Fig. 2).
Retrospective evaluation of real-time nanopore
sequencing
Two samples, one belonging to the outbreak and one
unrelated were sequenced on the newly-available Min-
ION from Oxford Nanopore Technologies. During the
outbreak, we used an early version of the chemistry
termed R6. However, results from this sequencing did
not produce sufficient numbers of high-quality two-
direction (2D) reads to be of use. In July 2014 R6 chem-
istry was replaced by R7, which we were able to evaluate
retrospectively. The MinION is characterised by very
long reads, which have a high error rate compared to
the Illumina platform.
Nanopore sequencing results
In order to evaluate the potential benefits of real-time
sequencing to enhance infection control procedures we
analysed read sets as they would have become available
in real time, that is, at 10 min intervals after the run had
been initiated. The two samples were run on separate
flow cells. The number of reads generated in the first
170 min were 2,865 (first flowcell) and 3,447 (second
flowcell) with mean read lengths of 6,340 and 4,664 bp,
respectively for each sequence library. The mean read
accuracy, determined by counting all differences from
18
10
Nursery
Student nurse
14-06-12 1x75bp (Draft)
13 samples 50.2% callable
14-06-20 2x250bp (v2)
24 samples 96% callable
14-07-04 2x300bp (v3)
41 samples 91.3% callable
2
29
A B C
Fig. 1 Phylogenetic reconstruction of the outbreak, as sequencing data were generated at three time points during the outbreak (corresponding
to Panels a, b and c). The red node demonstrates the most frequently occurring SNP type. Node labels show the number of isolates of this type.
Blue nodes are singletons. Edge labels show the number of SNPs between isolates. The turquoise node shows a cluster of two identical isolates
from cases associated with a nursery. The header bar shows the date of the sequencing, the Illumina sequencing protocol used, the number of
samples in the dataset and the total percentage of the S. Enteritidis reference genome which could be used for SNP calling (core genome).
Subtle differences in the number of SNPs between nodes on the tree may be seen, for example in the unrelated nursery isolates (6 SNPs different
between Panel a and Panel b). These differences are attributed to differences in core genome size, that is, the number of positions in the
reference genome used to generate the results. The precise core genome size figures are shown as a percentage in the panel headings
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the reference genome, was 72 % (first flowcell) and 73 %
(second flowcell).
Real-time strain identification from nanopore reads
We found that in the two samples tested we could un-
ambiguously identify the bacterial species S. enterica in
less than 30 min (Fig. 3). Additionally, chromosomally
encoded phage sequences were detectable and distin-
guishable between outbreak and non-outbreak strains
within 50 min.
Genotyping from low coverage, error-prone data using
phylogenetic placement
Genotyping accuracy improves as more sequencing data
are available and a consensus sequence is formed
(Table 1). Our genotyping protocol gets increasingly
more precise as more reads are added, however recall
stays relatively constant. Despite this, a phylogenetic
placement method confidently assigned both the out-
break and non-outbreak strains to a clade of S. enterica
containing the Gallinarum, Pullorum and Enteritidiis
serovars very early on in the sequencing process. By
40 min it was possible to determine that the likely sero-
var was Enteritidis (Fig. 4). Once assigned to a serovar,
further analysis could be restricted to a reference tree of
S. Enteritidis strains. It was possible then to show that
the outbreak strain unambiguously belonged to the main
hospital outbreak cluster within 100 min of starting se-
quencing (Fig. 5). The non-outbreak strain was assign-
able to a clade containing several closely related strains
(with a mixture of phage types, none of them PT 14b)
within 120 min.
The availability of definitive typing data so early on in
this outbreak enabled us to identify transmission be-
tween hospital wards and take rapid action to control
spread. The appearance of cases in unrelated wards was
puzzling initially, but WGS confirmed that the hospital
SNP type was the same as that circulating in the com-
munity. This reassured the infection control team that
there was not hospital-wide spread via some unknown
vector. Preliminary food sample testing results were only
available one day later. The finding of the outbreak
strain on the door seal of the food trolley with the subse-
quent confirmation of cases in staff members supported
the hypothesis that some local spread had occurred via
the environment. Person-to-person spread may also have
occurred. Towards the end of the outbreak the ability to
rapidly identify cases not involved prevented much wast-
age of effort and resources. Remarkably we identified
transmission of another strain of S. Enteriditis probably
acquired in Egypt in a childcare group at a distant site
because of the resolution of the typing information
directing epidemiological investigations. Recent out-
breaks of PT 14b strains in the UK have previously been
associated with Spanish eggs, although the antibiotic re-
sistance profile of the outbreak described here is differ-
ent [11, 12]. Contemporaneously, outbreaks of S.
Enteritidis PT 14b associated with consumption of eggs
were reported in France, Austria and Germany, trigger-
ing an urgent outbreak investigation by the ECDC and
EFSA [12]. Strains associated with this outbreak were of
Fig. 2 Phred-scaled quality scores (−10 log10 P) for Illumina sequencing demonstrating the impact of read length on read quality scores
with the three Illumina MiSeq sequencing modalities used in this study. Red scores indicate results from the draft 1 × 75 base sequencing
protocol, which shows minimally worse quality drop-off than running V2 (green, 2 × 250 base) or V3 chemistry (blue, 2 × 300) under
standard conditions
Quick et al. Genome Biology  (2015) 16:114 Page 4 of 14
MLVA type 2-12-7-3-2 (using the 5-locus scheme), vary-
ing by a single locus from the isolates identified in this
study. In these cases S. Enteritidis was isolated from eggs
originating from a producer in Germany [12]. There is
no definitive link between the outbreak reported in this
study and the consumption of German eggs. However,
the MLVA type in the European outbreak was also de-
tected in the UK and eggs from the German producer
are distributed for sale in the UK. Further whole-
genome sequencing of European isolates is now being
undertaken and may help determine whether the two
outbreaks are linked to a common source.
This study illustrates a substantial future benefit from
extremely rapid definitive WGS typing. The epidemi-
ology of non-typhoidal Salmonella has changed signifi-
cantly in the UK over the last decade and to a lesser
extent in the rest of Europe [2, 13]. While non-typhoidal
Salmonella rates have fallen overall, particularly in the
UK following chicken flock vaccination, the proportion
of disease caused by S. Enteritidis associated with travel
has risen greatly. The ability to both identify serovars via
deduced multi-locus sequence typing (MLST) and spe-
cific strains within a day of bacterial colonies being avail-
able will enable outbreaks to be investigated at a stage
where accurate travel/food histories and possible
person-to-person transmission can be elucidated and
control measures introduced. We show that our method
of rapid draft sequencing on the MiSeq is able to gener-
ate reliable results, despite generating reduced genome
coverage. We anticipate this method will be of value to
research groups needing to generate results in the time-
scale of a single working day, a considerable reduction
compared to the standard protocols on this instrument.
The availability of national and international databases
of sequencing data of food-borne pathogens marks an
exciting step forward for epidemiological investigations.
Surveillance by WGS has been pioneered by the US
Food and Drug Administration, with results published
online on the National Center for Biotechnology Infor-
mation’s GenomeTrakr service, an advantage of the port-
able, digital nature of genome data [8, 14]. In the UK,
since 1 April 2014, Public Health England has been rou-
tinely sequencing all Salmonella enterica strains re-
ported by hospitals and general practitioners to the
Salmonella Reference Service, Colindale. Through inte-
gration with this dataset, we determined that the out-
break strains formed a distinct cluster, although this
cluster varied by only a single core SNP from cases ob-
served elsewhere in the UK.
We evaluated two sequencing methodologies in this
study, both capable of providing rapid whole-genome se-
quencing information. The MinION senses individual
Non−outbreak Outbreak
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Fig. 3 Streaming taxonomic assignments from the Oxford Nanopore MinION are shown for an isolate belonging to the outbreak and an isolate
not belonging to the outbreak. Assignments to Salmonella and Salmonella enterica are found within 10 min of starting sequencing for the
outbreak strain and within 20 min for the non-outbreak strain. Phage-specific sequences are detected and are distinct between the non-outbreak
and outbreak strain. The non-outbreak strain harbours Salmonella phage ST64B and Gifsy-2, whereas the outbreak strain harbours Salmonella
phage RE2010
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Table 1 Streaming alignment statistics from nanopore data
Flowcell Time
(m)
Reads Bases Positions Missing
bases
Covered
(%)
True
positive
True
negative
False
positive
False
negative
Recall Precision Accuracy
Outbreak 60 920 5635627 7091 6463 8.86 10 617 0 2 0.83 1.00 0.09
Outbreak 120 2037 12853716 7091 4815 32.10 26 2237 7 7 0.79 0.79 0.32
Outbreak 180 3040 19297035 7091 3580 49.51 48 3436 13 15 0.76 0.79 0.49
Outbreak 240 3933 24900526 7091 2703 61.88 62 4291 17 19 0.77 0.78 0.61
Outbreak 300 4525 28614437 7091 2236 68.47 70 4736 25 25 0.74 0.74 0.68
Outbreak 360 5654 35848389 7091 1499 78.86 82 5454 26 31 0.73 0.76 0.78
Outbreak 420 6680 42498530 7091 1029 85.49 87 5914 25 37 0.70 0.78 0.85
Outbreak 480 7516 47950926 7091 749 89.44 94 6185 30 34 0.73 0.76 0.89
Outbreak 540 7913 50372188 7091 630 91.12 96 6300 29 37 0.72 0.77 0.90
Outbreak 600 8807 56254898 7091 463 93.47 103 6470 20 36 0.74 0.84 0.93
Outbreak 660 9666 61989423 7091 337 95.25 107 6588 22 38 0.74 0.83 0.94
Outbreak 720 10472 67171497 7091 267 96.23 111 6659 16 39 0.74 0.87 0.95
Outbreak 780 10833 69363106 7091 243 96.57 112 6686 16 35 0.76 0.88 0.96
Outbreak 840 11708 74625788 7091 191 97.31 117 6737 13 34 0.77 0.90 0.97
Outbreak 900 12479 79551399 7091 141 98.01 121 6780 16 34 0.78 0.88 0.97
Outbreak 960 13198 84228957 7091 120 98.31 124 6797 16 35 0.78 0.89 0.98
Outbreak 1020 13579 86600020 7091 107 98.49 125 6808 16 36 0.78 0.89 0.98
Outbreak 1080 14359 91437571 7091 90 98.73 126 6823 17 36 0.78 0.88 0.98
Outbreak 1140 15168 96646434 7091 74 98.96 124 6842 15 37 0.77 0.89 0.98
Outbreak 1200 15835 100970757 7091 70 99.01 123 6851 12 36 0.77 0.91 0.98
Outbreak 1260 16205 103367082 7091 63 99.11 124 6857 11 37 0.77 0.92 0.98
Outbreak 1320 16632 106040214 7091 60 99.15 125 6859 12 36 0.78 0.91 0.98
Outbreak 1380 17184 109618605 7091 56 99.21 125 6863 11 37 0.77 0.92 0.99
Outbreak 1440 17332 110500445 7091 55 99.22 124 6865 11 37 0.77 0.92 0.99
Non-
outbreak
60 1268 5382184 7091 6372 10.14 1 717 2 0 1.00 0.33 0.10
Non-
outbreak
120 2554 11567191 7091 4791 32.44 2 2284 15 0 1.00 0.12 0.32
Non-
outbreak
180 3626 17058822 7091 3451 51.33 4 3607 29 1 0.80 0.12 0.51
Non-
outbreak
240 4612 22004574 7091 2500 64.74 11 4545 32 4 0.73 0.26 0.64
Non-
outbreak
300 5483 26582592 7091 1760 75.18 13 5281 35 3 0.81 0.27 0.75
Non-
outbreak
360 6198 30340527 7091 1330 81.24 15 5705 40 2 0.88 0.27 0.81
Non-
outbreak
420 6877 34040490 7091 985 86.11 16 6054 35 2 0.89 0.31 0.86
Non-
outbreak
480 7522 37471113 7091 727 89.75 18 6306 37 4 0.82 0.33 0.89
Non-
outbreak
540 8306 41387560 7091 552 92.22 18 6483 34 5 0.78 0.35 0.92
Non-
outbreak
600 9032 45052523 7091 395 94.43 20 6643 28 6 0.77 0.42 0.94
Non-
outbreak
660 9682 48325820 7091 304 95.71 20 6735 27 6 0.77 0.43 0.95
Non-
outbreak
720 10262 51312827 7091 262 96.31 20 6783 21 6 0.77 0.49 0.96
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DNA strands as they move through a protein nanopore.
A unique property of this technology is that sequence
data are available in real time, and analysis can be per-
formed on a continuous stream of long reads. We
wished to evaluate the potential impact of a real-time
approach for analysis of clinical bacterial isolates. We
exploited this feature to perform rapid identification and
typing of genomic DNA prepared from a pure colony
isolate. Given the high error rate reads generated in this
study we employed a database of taxon-defining genes
from microbial species to make bacterial and bacterio-
phage identifications [15]. This approach is tolerant of
low-coverage, high-error reads making it useful for real-
time analysis of nanopore sequences. However, due to
the higher error rate of this platform, a de novo SNP
calling approach as utilised with MiSeq data would not
produce informative results within the short time scales
of interest here. Other studies have investigated the
error rate and mode of this instrument in greater detail
[15, 16, 17]. We show that despite the high error rate, ef-
fective genotyping is possible using phylogenetic place-
ment techniques. Phylogenetic placement has been used
to good effect in metagenomics studies where only low-
coverage data are available, for example in the diagnosis
of infectious diseases from ancient DNA samples, dir-
ectly from sputum and from the hospital environment
[18–20]. Using this approach, and a simple heuristic al-
gorithm to call the most likely genotype it was possible
to reliably place streaming nanopore data onto a refer-
ence phylogeny despite the high read error rate. Other
studies have shown that genotyping accuracy can reach
99 % when very high coverage (>120×) is available. This
would permit a de novo genotyping approach which did
not rely on phylogenetic placement, as is more typical in
studies employing traditional high-throughput sequen-
cing [14].
Both the draft sequencing protocol presented for the
MiSeq and the real-time evaluation of nanopore sequen-
cing demonstrate that these approaches have utility for
generating data of use in outbreak investigations in less
than one day (Fig. 6). It is not our intention here to per-
form direct comparisons between the instruments in this
study, particularly as they are quite different in their
mode of operation.
The MiSeq is typically run in a factory-style ‘batch’
mode, where many bacterial samples (up to 100 on a
MiSeq, or potentially many hundreds on the larger HiSeq
instrument) are run simultaneously, and processed in
Table 1 Streaming alignment statistics from nanopore data (Continued)
Non-
outbreak
780 10845 54417219 7091 202 97.15 21 6845 18 6 0.78 0.54 0.97
Non-
outbreak
840 11346 57135819 7091 178 97.49 22 6870 16 6 0.79 0.58 0.97
Non-
outbreak
900 11793 59514439 7091 145 97.96 23 6898 18 8 0.74 0.56 0.98
Non-
outbreak
960 12192 61590631 7091 111 98.43 22 6932 19 8 0.73 0.54 0.98
Non-
outbreak
1020 12571 63597395 7091 99 98.60 22 6944 19 8 0.73 0.54 0.98
Non-
outbreak
1080 12926 65415215 7091 87 98.77 21 6959 18 7 0.75 0.54 0.98
Non-
outbreak
1140 13263 67138579 7091 71 99.00 22 6976 15 8 0.73 0.59 0.99
Non-
outbreak
1200 13594 68911549 7091 62 99.13 22 6985 15 8 0.73 0.59 0.99
Non-
outbreak
1260 13881 70408443 7091 59 99.17 22 6992 11 8 0.73 0.67 0.99
Non-
outbreak
1320 14186 72080944 7091 53 99.25 23 7001 8 7 0.77 0.74 0.99
Non-
outbreak
1380 14471 73573256 7091 44 99.38 23 7008 10 7 0.77 0.70 0.99
Non-
outbreak
1440 14683 74801565 7091 40 99.44 23 7012 10 7 0.77 0.70 0.99
The columns show (from left to right): (1) the sample analysed; (2) the cumulative results at this time period (min); (3) the total number of two-direction reads;
(4) the total number of nucleotide bases; (5) the total size of the alignment; (6) the number of bases in the alignment missing from the dataset; (7) the percentage
of bases in the alignment that can be called; (8) the count of true positives; (9) the count of true negatives; (10) the count of false positives; (11) the count
of false negatives; (12) the recall, that is, sensitivity, calculated as TP/(TP + FN); (13) the precision, calculated as TP/(TP + FP); (14) the accuracy, calculated as
(TP + TN)/(P + N)
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Serovar Strain
Gallinarum 287/91
Gallinarum 9
Pullorum S06004
Gallinarum/ CDC1983-67
Pullorum ATCC 9120
Enteritidis 58-6482
Enteritidis 436
Enteritidis 6.0562-1
Enteritidis 13-Jan
Enteritidis 629164-37
Enteritidis 22704
Enteritidis 50-5646
Enteritidis 653049
Enteritidis 607308-16
Enteritidis 648904
Montevideo
Typhimurium
Newport
Typhi
Pullorum
Fig. 4 (See legend on next page.)
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serial at the end of the instrument operation. This ap-
proach reduces the cost of sequencing by taking advantage
of the very high output offered from these instruments
(>1 terabase for the HiSeq in High Output Mode). The
precipitous drop in the cost of sequencing bases has
meant that for bacterial applications the cost of library
preparation is rapidly becoming the most expensive com-
ponent. However, batch methods, particularly with the
very highest output modes result in a flexibility trade-off;
such an approach means that data cannot be analysed
until at least the barcode identifiers have been read (usu-
ally not until after halfway through the run).
This is in contrast to the real-time sequencing ap-
proach of the MinION whereby individual samples are
loaded, and results are generated and analysed in real
time until the results are sufficient to address the clinical
question. Such an approach has appealing properties for
applications such as infectious disease diagnostics. A
second attribute of the MinION that is notable is its ex-
treme portability, comparable in size to a USB flash
drive and requiring only a basic laptop to draw power
from and connect to. This suggests that it may, in
principle, be possible in the future to move sequencing
closer to the sample, and particularly when coupled with
a culture-independent approach.
However, at present the instrument depends on access
to a basic molecular biology laboratory infrastructure,
including access to freezer, and basic laboratory equip-
ment such as heater blocks and pipettes. The existing li-
brary preparation method, although relatively quick, is
quite labour-intensive for each sample. Presently there is
no method for multiplexing large numbers of bacterial
genomes (as with the MiSeq instrument), nor would the
throughput be amenable to this. Therefore, it seems
likely for large-scale surveillance efforts this platform is
not the obvious choice, for reasons of labour and cost.
Instead, we envisage that development of rapid library
preparation assays will be necessary in order to see this
platform become usable in a clinical microbiology la-
boratory or patient setting in the manner described here.
Furthermore, the need for culture enrichment remains
a significant bottleneck for rapid identification of bac-
teria and this also applies to other studies employing
whole-genome sequencing. Culturing of Salmonella
takes between 24 h (presumptive diagnosis) and 48 h
(pure culture for sequencing). Our approach, which re-
lies on sequencing single colonies from each sample, is a
limitation of this and similar studies. However, sequen-
cing of four individual colonies from the food trolley
demonstrated very limited heterogeneity with three iso-
lates being identical to the majority of other cases in the
outbreak, and one showing two SNP differences. A
culture-free approach for bacterial diagnostics has been
recently proposed and this would permit detection of
mixed infections as well as cutting down the time to result
significantly, for example in the case of direct sequencing
of Shiga-toxin producing E. coli from stool samples and
M. tuberculosis directly from sputum [21, 22]. However,
sequencing mixed communities reduces the genomic
coverage of the pathogenic target of interest, and so for
such an approach to be successful it is likely to rely on
generating greater throughput than currently achievable
on the MinION. Enrichment for the target organism, most
easily attained through traditional microbiology culture, is
therefore still a required stage.
Conclusion
The combination of rapid prospective sequencing during
an outbreak and detailed characterisation of cases occur-
ring on a national scale has potential implications for
the future of outbreak investigation [23]. We describe a
novel protocol for draft sequencing on the MiSeq that is
sufficiently quick to determine whether an outbreak is oc-
curring. For this vision to become a reality, further work
is needed to enable sharing of data between hospitals
and community practitioners with public health labora-
tories. Larger scale integration with national genome
databases represents the first implementation of a new
paradigm for the investigation of outbreaks. The use of
rapid, draft sequencing can delineate the context of an
outbreak very quickly even at lower than usual genome
coverage.
Materials and methods
Sample and bacterial culture collection
Faeces samples from patients with diarrhoea were sub-
mitted for culture and plated on XLD medium. Pre-
sumptive S. enterica isolates were confirmed using
biochemical tests and O- and H-antigen agglutination
sera and all those identified as S. Enteritidis were
retained for molecular typing. Environmental swabs were
taken from the affected wards within 24 h of the ward
clusters being identified and were processed as above.
(See figure on previous page.)
Fig. 4 Results of streaming phylogenetic placement from the Oxford Nanopore MinION on a reference tree of representative published
Salmonella enterica sequences. Common serovars of Salmonella are highlighted. Both outbreak and non-outbreak strains are unambiguously
identified as Salmonella enterica serovar Enteritidis by their position on the phylogenetic tree within 50 min. The line demonstrates the potential
range of placements reported by pplacer. The red placements indicate the positions of the outbreak isolate and the blue placements indicate the
positions of the non-outbreak isolate
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Time
Flowcell
Outbreak
Non-outbreak
Information Date
London 29.10.12
Anglia and Essex 28.11.12
London 31.5.14
Hants, IOW and Dorset 3.6.14
Beds, Herts and Northants 10.6.14
Beds, Herts and Northants 19.6.14
W Mids 20.5.14
Cumbria and Lancs 16.8.12
Anglia and Essex 30.4.12
Cumbria and Lancs 2.5.14
London 1.3.12
Avon, Glos and Wilts 10.4.14
W Mids 16.6.14
Beds, Herts and Northants 11.4.14
London 28.5.14
London 29.5.14
London 15.5.14
Thames Valley 18.6.14
Greater Manchester 1.4.14
Staff 6.6.14
Patient 9.6.14
Environment 13.6.14
Staff 4.6.14
Patient 3.6.14
Patient 5.6.14
Patient 20.6.14
Patient 6.6.14
Patient 10.6.14
Patient 6.6.14
Patient 13.6.14
Patient 30.5.14
Staff 10.6.14
Patient 12.6.14
Patient 4.6.14
Staff 9.6.14
Patient 2.6.14
Staff 13.6.14
Patient 14.6.14
Patient 2.6.14
Patient 15.6.14
Patient 6.6.14
Patient 3.6.14
Patient 2.6.14
Patient 4.6.14
Patient 6.6.14
Patient 2.6.14
Patient 4.6.14
Patient 9.6.14
Patient 1.6.14
Environmental 13.6.14
Environmental 13.6.14
Patient 3.6.14
Patient 19.6.14
Staff 19.6.14
Environmental 13.6.14
Patient 8.6.14
Patient 8.6.14
Staff 20.6.14
Patient 2.6.14
- -
Patient 4.6.14
Patient 4.6.14
Fig. 5 (See legend on next page.)
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(See figure on previous page.)
Fig. 5 Results of streaming phylogenetic placement from the Oxford Nanopore MinION on a reference tree of Salmonella enterica serovar
Enteritidis isolates collected by Public Health England during routine surveillance. The left-most panel demonstrates the confident placing of the
outbreak isolate in the outbreak clade within 100 min, and the confident placing of the non-outbreak isolate into a clade containing multiple
serotypes of Salmonella within 120 min. The red placements indicate the positions of the outbreak isolate and the blue placements indicate the
positions of the non-outbreak isolate. The right-most panel shows a phylogenetic reconstruction of isolates from the outbreak and their source,
set in context of a national outbreak of phage type 14b. Uncertainty in the phylogenetic placement technique is demonstrated early on in
sequence data collection due to the low accuracy of the variant calls collected. As more data are collected, the number of possible phylogenetic
placements reduces and the confidence values increase (not shown)
Fig. 6 A schematic showing time-to-result for the sequencing analysis strategies used in this study, starting from DNA input
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Genomic DNA extraction
Genomic DNA was prepared from nutrient agar slopes
incubated for 4–18 h at 37 °C. Cells were harvested
using 100 μL of sterile PBS added to the surface and a
sterile loop used to emulsify bacteria into a suspension
that was then pipetted into a sterile Eppendorf tube.
This suspension was used to harvest DNA with the
‘Invisorb spin cell mini kit’ (Invitek, Germany) according
to the manufacturer’s instructions. The quantity of DNA
in each sample was determined using a Qubit 2.0
fluorometer and dsDNA HS assay (Life Technologies,
Paisley, UK).
Library preparation for Illumina MiSeq sequencing
Sequence-ready libraries were generated from 1 ng DNA
per sample using the Nextera XT library preparation kit
(Illumina, Great Chesterford, UK) according to the man-
ufacturer’s instructions.
Rapid draft sequencing on the Illumina MiSeq
In order to provide results for an emergency infection
control meeting the next morning, we adapted the
standard sequencing protocol on the Illumina MiSeq to
rapidly generate sufficient data to analyse 16 strains. We
utilised a standard V3 600-cycle reagent kit. By modify-
ing the recipe files on the instrument we reduced the
chemistry time by 40 s per cycle and the number of tiles
imaged by 50 %. This resulted in a cycle time of approxi-
mately 3 min per cycle and allowed 75 base single-read
sequencing with dual barcoding to complete within 6 h.
We chose 75 base reads as a trade-off between expected
genome coverage and available time in order to have
results available sufficiently quickly for analysis. The
sequencing protocol can be downloaded from [24].
Standard sequencing on Illumina MiSeq and HiSeq
Later in the outbreak isolates were sequenced using
the Illumina MiSeq with standard V3 protocol at the
University of Birmingham, UK, also prepared with
Nextera XT reagents. In addition, some outbreak isolates
were sequenced on the Illumina HiSeq 2500 with TruSeq
V3 reagents as part of the Public Health England (PHE)
WGS sequencing pipeline at Colindale, UK (Additional
file 1: Table S1).
Phylogenetic reconstruction from draft sequencing
Before being mapped against the reference genome
S. Enteritidis P125109 (PRJNA59247) with BWA-MEM
(version 0.7.5), 75 base single-read data generated by
draft sequencing on the Illumina MiSeq was adapter
and quality trimmed with Trimmomatic [25, 26]. Single
nucleotide polymorphisms (SNPs) were called using
samtools mpileup (version 0.1.18) and VarScan (version
2.3.6), specifying a minimum read depth of 2 [27, 28].
Filtered SNPs (those positions with an allele frequency
of >80 % to call a variant or <20 % to call the reference
base in all samples) were extracted to make a concatenated
FASTA alignment. FastTree (version 2.1.7) was used to
generate an approximate maximum likelihood phylo-
genetic tree [29]. Phyloviz was used to produce mini-
mum spanning tree reconstructions [30]. Functional
annotation of these variants was performed using snpEff
(version 3.1) [31].
Phylogenetic reconstruction from PHE surveillance
sequencing
Before being mapped against the reference genome S.
Enteritidis AM933172 (PRJEA30687) with BWA-MEM,
100 base pair paired-end data generated on the Illumina
HiSeq 2500 was adapter and quality trimmed [26]. SNPs
were called using GATK [32]. High quality SNPs (>10-fold
coverage, >30 mapping quality, 90 % consensus) were
selected and uploaded into SNPdatabase (SNPdb). This
is an in-house PostgreSQL database containing genome
position and variant base for each SNP and low quality/
missing positions for all S. Enteritidis eBURST group 4
(EBG 4) isolates sequenced by PHE. SNPs in the core
genome of the strain set being analysed were extracted
from an in-house SNPdb and FastTree was used to
derive approximate maximum likelihood phylogenetic
trees. Annotation data came from the in-house PHE
GastroDataWarehouse (GDW).
Due to the clinical interest in these cases, strains with
below standard sequencing depth (30×) were analysed
and this had no impact on the analysis outcome, with
identical tree topologies detected in all cases.
Real-time sequencing on the MinION
An outbreak and a non-outbreak isolate, as determined
by earlier MiSeq sequencing, were chosen for sequen-
cing on the MinION (Oxford Nanopore Technologies,
Oxford, UK) to assess its suitability for future outbreak
investigations. High-molecular weight input DNA (1 μg)
was fragmented using a Covaris G-Tube (Covaris, Wo-
burn, USA) at 5,000 rpm in a centrifuge. Fragmented
DNA was end-repaired using the NEB repair module
(New England Biolabs, Ipswich, USA), then cleaned-up
using SPRI beads with a ratio of 1:1 beads to reaction
mixture. End-repaired DNA was then A-tailed using the
NEB A-tailing module. Following this a sequence-ready
library was generated using the gDNA sequencing kit
and protocol provided as part of the MinION access
program (MAP). The diluted library (150 μL) was loaded
into the MinION flowcell via the sample loading port. A
72-h sequencing protocol was initiated using the
MinION control software, MinKNOW (version 0.45.2.6).
Read event data were base-called by the software Metri-
chor (version 0.16.37960) using workflow 1.0.2_R7. The
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FASTA sequences and strand translocation times were
extracted for further analysis using the poretools FASTA
extraction function [33]. All sequence data are deposited
into the Short Read Archive (SRA) with study reference
ERP006904 (MinION data) and ERP007194 (Illumina
data).
Species identification from nanopore reads
Identification of bacterial and viral species present in
each sample was carried out using an alignment method
to the MetaPhlAn 2 database of taxon-defining marker
genes [33]. First, the database was extracted into FASTA
format using the fastacmd utility supplied with NCBI
BLAST. Alignment of nanopore reads was performed
using the LAST package (version 475), invoking lastal
with custom settings as per Quick et al. [15], using a
gap creation penalty and extension of 1 and a mismatch
penalty of 2 (match score 1), corresponding to command
line arguments -a1 -b1 -q2.
Subspecies level classification from nanopore reads
Serovars of S. enterica can often be assigned by phylo-
genetic methods. A phylogenetic reference tree was cre-
ated from the available draft or complete Salmonella
enterica genomes in RefSeq. From each of the sequences
600,000 simulated paired-end reads were generated
using wgsim (version 0.3.1) [34]. These were mapped
against the reference genome S. Typhimurium LT2
(PRJNA57799) with BWA-MEM (version 0.7.5) [26].
samtools mpileup (version 0.1.18) and VarScan (version
2.3.6) were used to call variants [27, 28]. Variant filtering
was done using filter_non_discriminatory_variants.py
[35] in order to remove non-discriminatory positions, as
well as heterozygous positions and regions of putative
recombination. Variant alleles for each sample were
concatenated into a fasta file using vcf2phyloviz.py [36].
This file was de-duplicated using the mogrify command in
seqmagick (version 0.6.0) to remove identical sequences
which can affect placements. A phylogenetic reconstruction
was created using FastTree (version 2.1.7) following a gen-
eralised time reversible model, after which taxtastic (version
0.5.1) was used to build the reference package [37].
To determine the subspecies level classification from
the nanopore sequencing data, the reads were mapped
against the reference genome with lastal with settings
-a1 -b1 -q2. For each read, the highest scoring alignment
was taken before being converted into BAM format
using samtools. Using samtools mpileup and the script
get_alleles_from_pileup.py the alignment was interro-
gated at all coordinates used for the reference tree.
Aligned bases at these coordinates were counted and the
dominant allele was used if at least two concordant bases
were in the alignment. Alleles were concatenated into
an alignment. Gap characters were used to represent
uncertain positions not meeting the above criteria. The
phylogenetic placement utility, pplacer, was used to
place the sequence onto the reference tree producing a
file containing the most likely position and logML prob-
ability for this placement. Placements with a likelihood
value of greater than −500 were excluded [37]. This place-
ment process was repeated for the read dataset available
at each timepoint (10 min apart). New reads generated
during each 10 min time interval were mapped to the ref-
erence, converted to a BAM file and merged with the
BAM file generated at the previous time period.
S. enterica outbreak reconstruction
As with the subspecies level classification, phylogenetic
placement can be used as a method for classifying sam-
ples in or out of an ongoing outbreak and in a national
and international context. In order to do this, we lever-
aged the routine surveillance sequencing of S. enterica
by PHE using 575 S. Enteritidis genomes of phage type
14b. Using the method described above a phylogenetic
reference tree was created for these genomes (448
remained after de-duplication) before the nanopore se-
quences were placed onto the tree to predict whether or
not they belonged to the outbreak cluster.
Additional file
Additional file 1: Table S1. Isolate identifiers sequenced in this study
using rapid draft MiSeq sequencing, standard MiSeq sequencing and
HiSeq sequencing during routine PHE surveillance.
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The Ebola virus outbreak was the largest on record and responsible for the deaths of 
more than 11,000 people. Genome sequencing has become an important tool in 
response to viral outbreaks as it can provide a high-resolution view of pathogen 
evolution. We developed a portable ‘lab-in-a-suitcase’ capable of generating Ebola 
virus genomes sequences in the field using the portable MinION sequencer. By 
performing the sequencing close to the samples we were able to reduce processing time 
to as little as 24 hours. In this way we could provide an up-to-date view of the outbreak 
to the Ebola national coordination team in Guinea over an 8-month period until the 
outbreak was declared over. This information could identify new cases as being part of 
known chains of transmissions which generally clustered geographically but 
occasionally were transmitted over large distances. Genome sequences were integrated 
in real-time with another group performing sequencing in neighbouring Sierra Leone 
allowing us to identify multiple cross-border transmission events. In total 142 genome 
sequences were generated and shared online at regular intervals through Github. The 
Ebola outbreak is the most highly sampled outbreak in history with over 5% of known 
cases sequenced and despite the magnitude of the tragedy we hope this can become a 
blueprint for future outbreak responses. 
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The Ebola virus disease epidemic in West Africa is the largest on 
record, responsible for over 28,599 cases and more than 11,299 
deaths1. Genome sequencing in viral outbreaks is desirable to 
characterize the infectious agent and determine its evolutionary rate. 
Genome sequencing also allows the identification of signatures of 
host adaptation, identification and monitoring of diagnostic targets, 
and characterization of responses to vaccines and treatments. The 
Ebola virus (EBOV) genome substitution rate in the Makona 
strain has been estimated at between 0.87 × 10−3 and 1.42 × 10−3 
mutations per site per year. This is equivalent to 16–27 mutations 
in each genome, meaning that sequences diverge rapidly enough 
to identify distinct sub-lineages during a prolonged epidemic2–7. 
Genome sequencing provides a high-resolution view of pathogen 
evolution and is increasingly sought after for outbreak surveillance. 
Sequence data may be used to guide control measures, but only if 
the results are generated quickly enough to inform interventions8. 
Genomic surveillance during the epidemic has been sporadic 
owing to a lack of local sequencing capacity coupled with practical 
difficulties transporting samples to remote sequencing facilities9. 
To address this problem, here we devise a genomic surveillance 
system that utilizes a novel nanopore DNA sequencing instrument. 
In April 2015 this system was transported in standard airline 
luggage to Guinea and used for real-time genomic surveillance of 
the ongoing epidemic. We present sequence data and analysis of 
142 EBOV samples collected during the period March to October 
2015. We were able to generate results less than 24 h after receiving 
an Ebola-positive sample, with the sequencing process taking as 
little as 15–60 min. We show that real-time genomic surveillance is 
possible in resource-limited settings and can be established rapidly 
to monitor outbreaks.
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5 Multiplex PCR method for MinION and Illumina sequencing of 
Zika and other virus genomes directly from clinical samples 
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experiments and wrote the manuscript. J.Q., A.D.S. and O.G.P. built the online primer 
design tool. All authors have read and approved the contents of the manuscript.  
 
5.2 Author contributions (additional detail) 
 
J.Q. developed the primer design tool, developed the laboratory protocol and performed 
the MinION validation experiments. J.Q. drafted the manuscript and all figures. 
 
5.3 Abstract 
 
Generating viral genomes from clinical samples can be challenging when the viral 
nucleic acid is present in very small amounts compared to a high background of host 
material. Zika virus infection produces a mild viremia and people often present to a 
physician after the peak viral load. The viral titre of typical Zika virus positive clinical 
samples is too low for metagenomic sequencing which when tested yielded small 
numbers of reads and incomplete genome coverage for a set of five clinical isolates. We 
instead developed a method for generation of many short overlapping amplicons in a 
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multiplex reaction. In order to simplify this process we built an online primer tool 
(primal.zibraproject.org) which automates the design procedure. We developed reaction 
conditions which could successfully generate amplicons covering most of the genome 
from real clinical samples up to Ct 36 representing very high sensitivity. We sequenced 
these amplicons using barcoding on the Oxford Nanopore MinION which reduced the 
cost to around $50 per sample when 12 samples were multiplexed on a single MinION 
flowcell. We produced a Docker container which enabling the generation of consensus 
sequences in a single pipeline which can be run on a laptop computer making it ideal for 
field situations. The general method is applicable to other viruses and we demonstrate 
the results of sequencing of Chikungunya virus reference material. Amplicon 
sequencing is a very sensitive method which makes it suitable for Zika virus sequencing 
however it has drawbacks including a reduction in efficiency when mismatches occur in 
primer binding sites, especially those close to the 3' end. This multiplex amplicon 
sequencing a useful tool in outbreak situations when strains are expected to be highly 
isogenic. It represents a robust and cost-effective method that can be performed in a day 
by someone who possesses basic molecular biology skills and we hope it will be useful 
method in future outbreaks. 
 
5.4 Published manuscript 
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Genome sequencing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing directly 
from clinical samples (i.e., without isolation and culture) remains challenging for viruses such as Zika, for which metagenomic 
sequencing methods may generate insufficient numbers of viral reads. Here we present a protocol for generating coding-sequence-
complete genomes, comprising an online primer design tool, a novel multiplex PCR enrichment protocol, optimized library 
preparation methods for the portable MinION sequencer (Oxford Nanopore Technologies) and the Illumina range of instruments, 
and a bioinformatics pipeline for generating consensus sequences. The MinION protocol does not require an Internet connection 
for analysis, making it suitable for field applications with limited connectivity. Our method relies on multiplex PCR for targeted 
enrichment of viral genomes from samples containing as few as 50 genome copies per reaction. Viral consensus sequences  
can be achieved in 1–2 d by starting with clinical samples and following a simple laboratory workflow. This method has been 
successfully used by several groups studying Zika virus evolution and is facilitating an understanding of the spread of the virus in 
the Americas. The protocol can be used to sequence other viral genomes using the online Primal Scheme primer designer software. 
It is suitable for sequencing either RNA or DNA viruses in the field during outbreaks or as an inexpensive, convenient method  
for use in the lab.
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6 Discussion 
 
Technology development 
 
Benchtop sequencing instruments were introduced in 2011 and provided researchers 
with a cost-effective option with sufficient power to tackle small to medium sized 
genomes. In the study of Pseudomonas aeruginosa in burns, 141 isolates were 
sequenced on an Illumina MiSeq instrument in batches of 24 over multiple runs. A 
significant advantage of benchtop instruments compared with larger instruments such as 
the HiSeq are the shortened run time and lower running costs. This in turn makes them 
more amenable to being drafted into use for outbreak sequencing quickly and on 
demand. Despite this, total turnaround times when including the time taken to perform 
library preparation and bioinformatics analysis may still be as long as a week, which 
may be too slow for urgent investigations. 
 
During the Salmonella outbreak the MiSeq sequencing was performed using a novel 
‘draft sequencing’ protocol. Common run modes for the MiSeq are 150 and 250 base 
paired-end sequencing that take up to 2.5 days to complete. These run modes are 
required for achieving the maximum run yield and improve the results for de novo 
assembly applications. We proposed that for rapid SNP calling the reads only need to be 
long enough for most to align unambiguously so set the read length to 75 bp. Reducing 
the read length meant we were able to reduce the chemistry time as higher rates of 
phasing could be tolerated. Illumina nucleotides have a bulky side chain with a 
fluorescent dye which is largely responsible for phasing, a measure of the completeness 
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of the incorporation reaction based on the amount of fluorescence still present for the 
previous base. If a cluster contains around 1000 molecules a phasing value of 0.1% 
means 10 strands are falling behind per cycle, resulting in reducing signal to noise ratio 
along the read. The final modification was to image only one surface, halving the time 
spent imaging. 
 
This outbreak in August 2014 coincided with early testing of the MinION sequencer. 
We wished to determine whether the MinION could provide clinically useful 
information during an ongoing bacterial outbreak. In addition to the 16 samples 
sequenced on the MiSeq in draft mode we also sequenced two isolates on the MinION, 
one from the outbreak and one unrelated strain. We first attempted this during the 
outbreak with the alpha version of the MinION chemistry R6 but we experienced poor 
results with very high error reads. We subsequently repeated the experiments using the 
updated R7 chemistry which yielded much higher numbers of 2D reads. The MinION 
analysis was therefore performed retrospectively. In order to simulate real-time data, 
reads were analysed as they would have become available in ten minute intervals after 
the start of the run. As well as having a shorter library preparation time than the MiSeq, 
we demonstrated two analysis methods that could rule isolates in or out of the outbreak 
within two hours of starting the run. This demonstrated that the MinION has an 
advantage in terms of speed over the MiSeq. This analysis relied on methods such as 
phylogenetic placement that compensated for the noisy data. Both methods were 
performed on DNA extracted from a pure culture which remains the rate limiting step 
regardless of the technology used. The sample to answer time could be in theory be 
significantly reduced if stool samples were tested directly using a metagenomics 
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approach such as during the German outbreak of Shiga-toxigenic Escherichia coli 
O104:H4[69]. It is not known however whether sequencing would generate sufficient 
genome coverage directly from clinical samples in order to accurately perform 
phylogenetic inference and this is complicated by the large number of related taxa in the 
normal human gut microbiome. 
 
Prior to the Salmonella study, we had used single molecule PacBio sequencing to 
generate a high-quality reference genome for the most common cluster ‘Clade E’ 
(ST395) in the Pseudomonas aeruginosa burns study. Library preparation and 
sequencing was performed by the Norwegian Sequencing Centre in Oslo on a PacBio 
RSII using the P5-C3 chemistry. The sequencing cost $1000 on an instrument that 
retails for $750,000. $1000 is still 10x the cost of sequencing a single isolate on an 
Illumina platform but it generated a near-complete reference genome which we could 
use for very high sensitivity ‘forensic-grade’ variant calling. This approach permitted us 
to generate very high-resolution phylogenetic trees of a group of very closely related 
isolates to reveal microdiversity. In contrast, the simplicity of the MinION instrument 
means it can be provided effectively free of charge as a part of a $1000 MinION starter 
pack. As there are no infrastructure or instrument amortisation costs to worry about the 
real cost of sequencing is the same at the reagents and flowcells. In the Ebola study we 
sequenced one genome per flowcell without using any barcoding. This meant that the 
cost per sample was >$500, which is expensive but it allowed the fastest possible 
turnaround of as little as 24 hours. In later projects including Zika sequencing we 
reduced the cost by sequencing 12 samples per flowcell through the use of the native 
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barcoding kit. Provided the throughput is high enough samples could be further 
multiplexed to 96 samples per flowcell using the PCR barcoding kit. 
 
At the 2017 London Calling conference Oxford Nanopore technologies announced that 
a 128 channel low-cost flowcell was in development. In this new design, the 
application-specific integrated circuit (ASIC) which performs low level analogue-to-
digital conversion would remain on the MinION reducing the cost of the flowcell. A 
low-cost flowcell such as this would be ideal for viral surveillance applications where 
typical flowcell yields of a few gigabases are overkill for sequencing small viral 
genomes. Generating sufficient coverage of a single Ebola virus genome took as little as 
15 minutes on a standard flowcell so would be run for 2 hours on a low-cost flowcell, 
while 12 Zika virus genomes which would usually take 4 hours would be run overnight. 
If the laborious barcoding protocol could be simplified then barcoded samples could be 
continuously loaded onto the flowcell when ready. The cholesterol tethers on the 
sequencing adapters adsorb DNA fragments to the membranes allowing new samples to 
be added to an ongoing run on top of the previous sample. Exploiting this with a ‘run 
until’ system guiding loading could be used in future to improve efficiency and reduce 
per sample costs.  
 
Nanopore sequencing technology offers three clear advantages over existing 
technology; portability, low cost and long read lengths. Other technologies rely on 
complex optical based detection methods with lenses which need calibration after 
installation. In addition, all technologies require large volumes of reagents and a fluidics 
system to deliver them which has severely hampered miniaturisation efforts. The 
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MinION uses electrophysical detection so has neither of these limitations. In addition, 
the device draws less than one ampere so can be powered from the USB port of a laptop 
computer. The laptop can also provide the compute required for data collection and 
basecalling. This means that the samples can be sequenced close to where they were 
collected for the fastest time from sample to answer rather than shipping them to the 
sequencing facility and the difficulties associated with exporting samples. 
 
Mobile laboratories 
 
Genome sequencing during outbreaks can inform the public health response to 
infection, but only if results can be generated quickly enough. Previously, samples from 
an outbreak zone needed to be collected, shipped to a well-equipped laboratory, 
sequenced and analysed before they can be used to guide public health measures. 
Jeremy Farrar, director of the Wellcome Trust said surveillance “is largely stamp 
collecting” unless response times can be “counted in days, at most weeks, not months 
and years”. The MinION offers the first practical real-time genome surveillance system.  
 
For the Ebola study we assembled a mobile ‘lab-in-a-suitcase’ which was transported as 
standard airline luggage. It consists of a thermocycler, pipettes, consumables and 
temperature controlled reagents in polystyrene boxes. On arrival, the reagents were 
transferred to a fridge freezer already in the lab at Donka Hospital, Conakry. Power for 
the fridge freezer and thermocycler was provided by the grid with generator backup. 
The laboratory was able to be moved twice as the outbreak progressed to where it was 
most needed, both locations had mains power with generator backup. This worked 
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effectively during the Ebola virus outbreak because the sequencing functionality was a 
bolt-on to the diagnostic lab which was performed RNA extraction and RT-qPCR to 
provide a rapid diagnostic service. These labs were situated at Ebola treatment centres 
run by NGOs who built and maintained the infrastructure required. These centres take 
time to establish and would not be available in the initial days or weeks of a new 
outbreak. A truly portable surveillance system should be portable enough to access 
remote areas and should be able to safely process infectious material by the use of a 
portable isolator. Using a suitable lithium ion battery to power the equipment with a 
solar panel for full ‘off-grid’ sequencing would allow sequencing in remote areas where 
no power is available. We have successfully used the miniPCR, Qubit fluorimeter and 
minifuge on battery power in the field. Ideally all reagents should be lyophilised to 
allow long term storage at ambient temperature. Primers and RT-PCR reagents are 
readily available in lyophilised formats. These reagents will typically use trehalose as an 
additive which is an excellent protein stabiliser. If an amplicon sequencing method is 
being used then primers and reagents could be prepared and lyophilised in advance 
allowing for a one-tube ‘resuspend in sample’ type library preparation minimising the 
risk of contamination. 
 
In 2015 during the Ebola outbreak the only basecaller available was the cloud service 
Metrichor which meant FAST5 read files needed to be uploaded for basecalling. The 
FAST5 files themselves were needed downstream for the event data so performing 
basecalling in country would not have been productive. We transferred unbasecalled 
files by making a TAR.GZ of 10,000 FAST5 files for each sample. The resulting ~500 
Mb file was uploaded to Google Drive as this supported resuming interrupted uploads. 
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This file was downloaded to servers in Birmingham for basecalling using Metrichor and 
downstream analysis. This required the development of a new ‘variants’ module in 
Nanopolish developed by Jared Simpson and a new 6-mer pore model in order to 
produce accurate SNP calls. We validated the results by resequencing five samples 
using Illumina technology and demonstrated that the calls were 100% concordant. 
 
Sequencing methodology 
 
When travelling to Guinea for the Ebola study we transported reagents to perform both 
the amplicon method and a metagenomics approach which we didn’t use beyond two 
trial runs as it generated poor results. Difficulties in uploading only 10,000 amplicon 
reads over a 3G connection meant that the metagenomics based approach was 
impractical in the situation. Although effective the Ebola RT-PCR scheme was still 
laborious, it required 12 PCR reactions to be set up, cleaned up and quantified per 
sample (11 regions plus a negative control). The PCR machine I transported was only a 
small 25 well instrument which limited the number of samples to two per day. 
 
For Zika virus sequencing an amplicon method was chosen as we had experience with 
them from sequencing Ebola and we knew offered the highest sensitivity. There were 
reports that other groups were having difficulties sequencing Zika virus due to low viral 
titre in clinical samples. The modal Ct value for Zika positive patients turned out to be 
36 in the large study into the establishment of Zika virus in Brazil[70] equivalent to 
only 10 genome copies per µl of RNA. Fragment lengths in nucleic acid extractions are 
usually normally distributed so having a high titre increases the likelihood of there 
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being long template molecules. When sequencing Ebola we used fewer longer 
amplicons, which was possible due to the high titre. In order to overcome the low titre 
problem with Zika virus we focused on short 400 bp amplicons which meant no longer 
exploiting the long-read capabilities of the MinION yet it was now compatible with 
Illumina read lengths. To generate the tiling amplicons for sequencing we would need 
35 individual PCR reactions yet if we could generate the amplicons in a multiplex PCR 
we could combine it with barcoding to achieve 420 amplicons per flowcell or 12 Zika 
virus genomes. Pooling even and odd regions together allowed us to generate the 
amplicon products in two reactions per sample or 24 reactions per flowcell each with 
non-overlapping products. Making this work required designing primers with high 
annealing temperatures to reduce the favourability of non-specific primer interactions. 
We used a low primer concentration and a two-step thermocycler program with a long, 
combined annealing and extension step of 5 minutes. These conditions gave successful 
amplification up to Ct 36 which meant we had for the first time a method available 
which could sequence a typical clinical sample. 
 
The benefits of amplicon sequencing are that it is robust, inexpensive and can be done 
in a day (and potentially much faster with optimisation). The multiplex method 
published describes an online tool (primal.zibraproject.org) for automated primers 
design and the PCR conditions for two-step RT-PCR for sequencing Zika virus and 
Chikungunya although the method could be applied to a broader range of viruses. Two-
step RT-PCR means the reverse transcription is done in a separate reaction to the PCR. 
This was used for two reasons; it allows the use of random primers for the RT step but 
specific primers for the PCR and it is more sensitive as each step can use the optimal 
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buffer. We also provided an optimised library production for both MinION and Illumina 
sequencing. This was required particularly for MinION sequencing as the 400 bp 
products are considerably shorter than the typical fragment length requiring the input to 
be reduced to achieve the expected molarity for ligation. The barcoding process itself is 
still too laborious, requiring end-preparation and barcode ligation before pooling and 
sequencing adapter ligation. With further work It will be possible to eliminate need for a 
standalone barcode ligation by adding it with a second round PCR. This could be one 
possible path to a fully portable, lyophilised sample preparation for use in the field.  
 
Amplicon sequencing unfortunately has many limitations chiefly that is requires a 
priori knowledge of the outbreak strain in order to design working primers. A downside 
of the high specificity of PCR is that it is sensitive to mismatches in the primer binding 
sites such would be expected in other lineages or strains. This makes it more suitable to 
outbreak work than to population scale surveillance efforts. In this situation bait capture 
may be more suitable as the baits are typically longer and therefore more tolerant to 
mismatches, potentially up to 30% sequence divergence. In in the case of an unknown 
pathogen you would have to switch to a meta-transcriptomics approach. This is usually 
done by filtering a sample through a 0.22 µm filter to remove cells and treating with 
DNAse to degrade any extracellular DNA before doing the extraction. The sensitivity of 
this method is dependent on the relative abundance of the virus of interest with respect 
to the background. Both bait capture and metagenomics methods are significantly more 
laborious than amplicon sequencing and may not be practical for a mobile laboratory 
setting. One problem highlighted by working on low titre samples was the need for 
meticulous contamination prevention measures which is more difficult in long multi 
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stage protocols than for PCR which can be set up in a hood. Dedicated PCR hoods must 
be used for preparing master mix and adding template to prevent amplicons 
contaminating subsequent reactions. 
 
Real-time analysis 
 
Nanopore sequencing presents a new paradigm for real-time analysis because it is the 
first technology that generates full length reads during the run. Most of technologies do 
not ‘reload’ so the reads are only available after the run finishes. In the Salmonella 
study we sought to explore how long it would take to get to the answer rather than the 
answer itself. To do this we generated read sets using the time stamps in the reads of 
reads that were available in ten minute windows. We investigated methods we expected 
to be robust to either noisy long-reads or low coverage. The first analysis approach was 
aligning reads to the MetaPhaAn database of taxon defining genes. Detecting presence 
or absence of genes is tolerant to a high error rate in the reads as the probability of a 
long read aligning by chance is very low. Using this method we could unambiguously 
identify the species as Salmonella enterica within 30 minutes. Differences between the 
outbreak and the non-outbreak strain were also observed after 50 minutes as three 
different chromosomally encoded phages were detected as we generated more coverage; 
Gifsy 2 in the outbreak strain and ST64B/RE_2010 in the non-outbreak strain. Two 
reads were identified as originating from Citrobacter freundii however as this is another 
member of the family Enterobacteriaceae it was most likely a missassigned at a lower 
rank than it should have been. 
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The second approach used phylogenetic placement to place new samples on tree build 
using Salmonella enterica and Salmonella enterica serovar Enteritidis genomes. With 
this method it was possible to determine after 40 minutes that both samples were likely 
from the serovar Enteritidis. The same process repeated using a reference tree 
containing only Enteritidis isolates, was able to assign one sample to the main hospital 
cluster after 100 minutes. The other sample could be assigned to a different cluster 
containing a mixture of phage types none of which were the same as the hospital cluster 
(14b), after 120 minutes. Surveillance sequencing of foodborne pathogens by WGS is 
an exciting development pioneered by the Food and Drug Administration (FDA) in the 
US[68]. Since the 1st April 2014, Public Health England (PHE) has also routinely 
sequenced all Salmonella isolates referred by hospitals and general practitioners to the 
Salmonella Reference Laboratory, Colindale. Having this data available enabled us to 
perform the phylogenetic placement analysis using the MinION data for the Enteritidis 
clade and have sufficient resolution to be able to distinguish the outbreak sample from 
the non-outbreak sample. For organisms other than Salmonella that do not get routinely 
sequenced by PHE, identification via the presence marker genes could be performed 
however this would lack the resolution to be able to distinguish between closely related 
strains. In this case only species level assignment was possible.  
 
Surveillance sequencing 
 
The cost and ease of sequencing bacterial genomes and the high-resolution, digital 
output mean whole-genome sequencing will eventually become the routine method for 
epidemiological surveillance. Currently most studies are snapshots and managed by 
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different groups of experts, usually on a pathogen by pathogen basis. Online tools such 
as nextstrain.org can integrate whole-genome data and metadata in real-time and 
provide up to date data for integration by public health investigators rather than trying 
to find the information in a published study. In the UK, routine surveillance sequencing 
is limited to food borne pathogens and Mycobacterium tuberculosis referred via the 
reference laboratory. An outbreak of Salmonella enterica such as the one we had, was 
one of the few that could have been integrated with the national surveillance data. The 
genomes generated by the Illumina MiSeq were compared to existing sequences in the 
Public Health England GastroDataWarehouse and the US GenomeTrakr service to look 
for national and international links. The outbreak samples were found to form a distinct 
cluster but this was closely related (1 SNP) to other cases form the UK. There were not 
any closely linked samples in GenomeTrakr which was expected as most of the food 
consumed in the UK is produced within the European Union. This data was a powerful 
tool enabling us to quickly place the outbreak in a national context. The source was 
eventually tracked down to a German egg producer known to authorities for frequent 
breaches of food safety standards. It seems likely that people will become accustomed 
to the power of surveillance sequencing for the species it is available for and this will 
lead to a shift from conventional reference laboratory identification and typing in favour 
of whole-genome sequencing for all pathogens. 
 
During the Ebola outbreak data was disseminated as soon as it was available to 
epidemiologists working in field either via a Microreact[71] URL or later by a scripted 
PDF report. These contained phylogenetic trees for each cluster and incorporated 
metadata provided by the field lab. After an embargo period implemented on request of 
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the central coordination they were pushed to a publically available github repository and 
nextstrain.org. There were two main lineages circulating; GN1 and SL3, and multiple 
epidemiological transmission chains. GN1 related to early cases in Guinea and another 
linked to SL3 first detected in Sierra Leone in 2014. The real-time genomic surveillance 
data helped field epidemiologists confirm or reject the proposed transmission chains. 
This was particularly useful in cases where communities were difficult to access e.g. an 
itinerant fishing community in Boké prefecture. There were some popular rumours at 
the time that organs were being harvested under the guise of Ebola research 
(http://www.thesierraleonetelegraph.com/sierra-leone-human-tissues-and-organs-
harvested-for-trafficking/) making some distrusting or even hostile to outsiders. 
Integration of our data with another group who had been generating genome sequencing 
in Sierra Leone using Ion Torrent sequencing revealed frequent cross border 
transmissions which was fed back to the epidemiologist on the ground. One issue that 
we experienced was that metadata provided from the field often required cleansing. This 
was partly down to the fact that information was entered into an Excel workbook which 
led to many different date formats and unwanted conversions to occur. The second issue 
was multiple spellings being provided for the same village due to variations in oral 
tradition. This could be overcome using a prebuilt database with fixed format fields for 
data entry and drop downs for any metadata which may be available from existing 
mapping. 
 
Metagenomics as a way to identify potential pathogens in the hospital environment 
could be a powerful technique. In the burns study a thermostatic mixer value was 
removed from a persistently positive outlet and we were able to sample the biofilm 
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found inside for metagenomic sequencing. The reads obtained were aligned to the non-
redundant nucleotide database using BLAST and the most abundant taxon was found to 
be P. aeruginosa. Alignment against the Clade E reference showed that 5x coverage of 
the genome was obtained and using a phylogenetic placement method the sample 
clustered with other isolates from the shower in room nine, the outlet from which the 
component had been removed. Without the requirement for culture positive outlets 
could be identified more rapidly reducing the change of a patient being exposed. 
Sequencing could also be used to determine if a water sample contains safe levels of P. 
aeruginosa using a spike in of known input to calibrate. Metagenomic sequencing also 
has the advantage of being open-ended and is not restricted as a laboratory test might be 
to a specific set of validated organisms. For example the individual colony forming unit 
assays performed individually for P. aeruginosa, Legionella pneumophila and coliform 
bacteria could be combined into a single test while also being able to detect rarer 
pathogens such as Mycobacterium chelonae that would not be routinely tested. 
 
Epidemiological inference 
 
The complexity of epidemiological interpretation is outbreak and pathogen dependent. 
The Ebola outbreak was likely a single spillover event from an infected bat to a child. 
As this represents a point source introduction followed by continued human to human 
transmission we can say with some certainty that all cases are descended from that 
index case. This provides the simplest interpretation as for each new sample the closest 
neighbour in the tree should represent the most recent sampled ancestor.  
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Zika virus originated in Uganda where it cycled between non-human primates and 
Aedes mosquitos in the sylvanic cycle, with occasional spillover into humans causing 
small outbreaks. The current pandemic was a result of it changing to cycling between 
humans and mosquitos in the urban cycle before being introduced to Southeast Asia, 
Oceania and the Americas. Multiple introductions and the possibility that the virus 
could return to the sylvanic cycle make epidemiological inference more complex. In 
addition the outbreak was very poorly sampled; in 2016 there were only 23 Zika virus 
genome sequences from Brazil limiting the resolution of phylogenetic reconstructions. 
We generated and additional 54 partial genomes using the amplicon sequencing method 
we developed and other groups generated 149 others after we published the method 
online[72, 73]. Combining all the datasets allowed a detailed phylogenetic 
reconstruction to be performed which suggested northeast Brazil being the source of 
Zika virus in the Americas with onward spread from there. The virus circulated 
undetected in Brazil was masked by the endemic dengue and Chikungunya circulating 
in the country. This was an important finding to meaning the baseline for microcephaly 
before Zika virus needed to be taken earlier. This project again demonstrated the 
importance of the MinION as a tool for digital surveillance. At relatively low cost, we 
outfitted three labs in Brazil with all the equipment required to perform Zika virus 
sequencing on MinION. The amplicon sequencing method is able to generate genomes 
from mosquitos without altering the protocol and doing so allows you to link the cases 
back to mosquitos trapped in a particular area. It is assumed that Aedes aegypti is the 
sole mosquito vector but this may not be the case and detection in other species could 
dramatically alter the areas of the country at risk. Understanding the phylogeography of 
Zika virus can inform public health interventions such as mosquito eradication drives 
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e.g. if a large city was at risk. The genome sequence can alert you to any possible 
mutations in the genome in diagnostic regions which could sensitivity of important 
diagnostic tests. 
 
Epidemiological investigations to investigate food or water borne outbreaks can 
produce ambiguous results as it is more likely that diversity may be transmitted. In the 
Salmonella enterica outbreak the contaminated eggs were tracked down to a European 
egg producer. Although this represents a continuous point source outbreak diversity had 
built up in the infected flock meaning isolates recovered from patients in the outbreak 
may not be identical to those from the flock by whole genome sequencing if sampling is 
insufficient. If an isolate however falls within a ‘cloud of diversity’ it is still strong 
evidence for that being the source. Similarly, in the burns study we discovered diversity 
between the water outlets on the ward but not within a single outlet. This suggests the 
introduction of diversity via the water supply, followed by the establishment of a 
biofilm community in the outlets. The evolutionary rate within a biofilm should be slow 
as it is a nutrient limited environment and the lack of diversity within an individual 
outlet supports this. The total diversity we observe in the burns ward is low compared to 
what you might expect to find in the environment however which is suggestive of an 
evolutionary bottle neck as some point in the past, whether this occurred within the 
hospital plumbing network is not known. The diversity between outlets however 
provided us with a method of identifying the likely outlet from which a patient became 
infected i.e. a ‘map of genotypes’. Phylogenetic reconstruction within the clade showed 
clear evidence of clustering by room and outlet. It was high enough resolution in some 
instances that it was possible to distinguish between the tap and shower in room 11 and 
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this was consistent over multiple samples. This approach of generating a geographical 
map of genotypes means that any subsequent epidemiological investigation could be 
performed very quickly. One of the things holding back routine use whole-genome 
sequencing in epidemiological investigations is knowledge of the populations structure 
of certain organisms. 
 
Summary 
 
We are on the cusp of an exciting revolution in genomic epidemiology systems. We 
have portable nanopore sequencing technology which has proven robust enough to be 
transported in an airline or even a space rocket hold. Fieldable methods for amplicon 
sequencing can be used to generate genomes from low titre samples and sequence them 
within in a day. Offline analysis pipelines installed on a laptop can generate consensus 
sequences and place new samples in the context of the outbreak allowing information to 
feedback into the outbreak response. There are many so advantages to whole-genome 
for pathogen surveillance it is inevitable that it will eventually replace conventional 
typing methods and continued development in the technology will enable cost effective 
surveillance sequencing to detect and track outbreaks in hospitals and in the field alike. 
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